c35bb9f13842578543495eaec21f2ea68c19d18b
BL_genes_with_bib.md
| ... | ... | @@ -0,0 +1,562 @@ |
| 1 | +# BL genes |
|
| 2 | + |
|
| 3 | +## Origins of BL genes |
|
| 4 | + |
|
| 5 | +## Tier 1 BL genes |
|
| 6 | + |
|
| 7 | +| Gene | Tier | Relevant references | |
|
| 8 | +|:------------------:|:----:|:-------------------------------------------------------------:| |
|
| 9 | +| [ARID1A](ARID1A) | 1 | (Love et al. 2012; Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 10 | +| [BMP7](BMP7) | 1 | (Panea et al. 2019) | |
|
| 11 | +| [CCND3](CCND3) | 1 | (Richter et al. 2012; Morin et al. 2011, 2011) | |
|
| 12 | +| [CHD8](CHD8) | 1 | (Grande et al. 2019; Reddy et al. 2017) | |
|
| 13 | +| [DDX3X](DDX3X) | 1 | (Schmitz et al. 2012, 2018) | |
|
| 14 | +| [EIF4A1](EIF4A1) | 1 | (Panea et al. 2019) | |
|
| 15 | +| [EPPK1](EPPK1) | 1 | (Panea et al. 2019) | |
|
| 16 | +| [FBXO11](FBXO11) | 1 | (Richter et al. 2012; Hübschmann et al. 2021) | |
|
| 17 | +| [FOXO1](FOXO1) | 1 | (Schmitz et al. 2012; Morin et al. 2011, 2011) | |
|
| 18 | +| [GNA13](GNA13) | 1 | (Love et al. 2012; Morin et al. 2011, 2011) | |
|
| 19 | +| [GNAI2](GNAI2) | 1 | (Grande et al. 2019; Morin et al. 2013) | |
|
| 20 | +| [HNRNPU](HNRNPU) | 1 | (Panea et al. 2019; Reddy et al. 2017) | |
|
| 21 | +| [ID3](ID3) | 1 | (Richter et al. 2012; Schmitz et al. 2012) | |
|
| 22 | +| [KMT2D](KMT2D) | 1 | (Grande et al. 2019; Morin et al. 2011, 2011) | |
|
| 23 | +| [MYC](MYC) | 1 | (Johnston and Carroll 1992; L. Pasqualucci et al. 2001) | |
|
| 24 | +| [P2RY8](P2RY8) | 1 | (Muppidi et al. 2014; Lohr et al. 2012) | |
|
| 25 | +| [PHF6](PHF6) | 1 | (Thomas et al. 2023; Reddy et al. 2017) | |
|
| 26 | +| [PTEN](PTEN) | 1 | (Love et al. 2012) | |
|
| 27 | +| [RFX7](RFX7) | 1 | (Grande et al. 2019) | |
|
| 28 | +| [RHOA](RHOA) | 1 | (Richter et al. 2012; L. Pasqualucci et al. 2001) | |
|
| 29 | +| [SIN3A](SIN3A) | 1 | (Grande et al. 2019) | |
|
| 30 | +| [SMARCA4](SMARCA4) | 1 | (Richter et al. 2012; Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 31 | +| [TCF3](TCF3) | 1 | (Schmitz et al. 2012) | |
|
| 32 | +| [TCL1A](TCL1A) | 1 | (Grande et al. 2019) | |
|
| 33 | +| [TFAP4](TFAP4) | 1 | (Grande et al. 2019) | |
|
| 34 | +| [TP53](TP53) | 1 | (Wilda et al. 2004; Morin et al. 2011) | |
|
| 35 | +| [USP7](USP7) | 1 | (Grande et al. 2019) | |
|
| 36 | +| [WNK1](WNK1) | 1 | (Thomas et al. 2023; Hübschmann et al. 2021) | |
|
| 37 | + |
|
| 38 | +## Tier 2 BL genes |
|
| 39 | + |
|
| 40 | +| Gene | Tier | Relevant references | |
|
| 41 | +|:----------------------:|:----:|:---------------------------------------------------------------------------------------------------------:| |
|
| 42 | +| [ACAD9](ACAD9) | 2 | (Love et al. 2012) | |
|
| 43 | +| [ACE](ACE) | 2 | (Love et al. 2012) | |
|
| 44 | +| [ADAMTS5](ADAMTS5) | 2 | (Burkhardt et al. 2022) | |
|
| 45 | +| [ADNP](ADNP) | 2 | (Burkhardt et al. 2022) | |
|
| 46 | +| [AGO4](AGO4) | 2 | (Burkhardt et al. 2022) | |
|
| 47 | +| [ALPK2](ALPK2) | 2 | (Panea et al. 2019) | |
|
| 48 | +| [ARHGEF1](ARHGEF1) | 2 | (Muppidi et al. 2014) | |
|
| 49 | +| [ATP2C2](ATP2C2) | 2 | (Love et al. 2012) | |
|
| 50 | +| [BACH2](BACH2) | 2 | (Grande et al. 2019) | |
|
| 51 | +| [BCL2](BCL2) | 2 | (Burkhardt et al. 2022; Morin et al. 2011; Tanaka et al. 1992) | |
|
| 52 | +| [BCL6](BCL6) | 2 | (Love et al. 2012; Morin et al. 2011) | |
|
| 53 | +| [BCL7A](BCL7A) | 2 | (Grande et al. 2019; Krysiak et al. 2017; Arthur et al. 2018) | |
|
| 54 | +| [BRAF](BRAF) | 2 | (Love et al. 2012; Tiacci et al. 2011) | |
|
| 55 | +| [BRD4](BRD4) | 2 | (Love et al. 2012) | |
|
| 56 | +| [BTG1](BTG1) | 2 | (Burkhardt et al. 2022; Morin et al. 2011) | |
|
| 57 | +| [BTG2](BTG2) | 2 | (Love et al. 2012; Morin et al. 2011, 2011) | |
|
| 58 | +| [C16orf48](C16orf48) | 2 | (Schmitz et al. 2012) | |
|
| 59 | +| [C6orf27](C6orf27) | 2 | (Love et al. 2012) | |
|
| 60 | +| [CAD](CAD) | 2 | (Love et al. 2012) | |
|
| 61 | +| [CARD11](CARD11) | 2 | (Panea et al. 2019; Morin et al. 2011; Lenz et al. 2008) | |
|
| 62 | +| [CARD4](CARD4) | 2 | (Love et al. 2012) | |
|
| 63 | +| [CCNF](CCNF) | 2 | (Abate et al. 2015) | |
|
| 64 | +| [CCT6B](CCT6B) | 2 | (Love et al. 2012) | |
|
| 65 | +| [CD79A](CD79A) | 2 | (Burkhardt et al. 2022) | |
|
| 66 | +| [CD79B](CD79B) | 2 | (Panea et al. 2019; Morin et al. 2011) | |
|
| 67 | +| [CD83](CD83) | 2 | (Panea et al. 2019; Russler-Germain et al. 2023; Morin et al. 2013) | |
|
| 68 | +| [CDC73](CDC73) | 2 | (Love et al. 2012; Reddy et al. 2017) | |
|
| 69 | +| [CDH17](CDH17) | 2 | (Love et al. 2012) | |
|
| 70 | +| [CDKN2A](CDKN2A) | 2 | (Grande et al. 2019; Morin et al. 2013) | |
|
| 71 | +| [CDKN2C](CDKN2C) | 2 | (Thomas et al. 2023) | |
|
| 72 | +| [CHD4](CHD4) | 2 | (Burkhardt et al. 2022) | |
|
| 73 | +| [COL4A2](COL4A2) | 2 | (Love et al. 2012) | |
|
| 74 | +| [CPXM2](CPXM2) | 2 | (Burkhardt et al. 2022) | |
|
| 75 | +| [CREBBP](CREBBP) | 2 | (Love et al. 2012; Laura Pasqualucci, Dominguez-Sola, et al. 2011, 2011) | |
|
| 76 | +| [CTCF](CTCF) | 2 | (Panea et al. 2019) | |
|
| 77 | +| [CXCR4](CXCR4) | 2 | (Panea et al. 2019; Krysiak et al. 2017; Khodabakhshi et al. 2012) | |
|
| 78 | +| [CYB5D1](CYB5D1) | 2 | (Love et al. 2012) | |
|
| 79 | +| [CYP4F22](CYP4F22) | 2 | (Love et al. 2012) | |
|
| 80 | +| [DHCR7](DHCR7) | 2 | (Schmitz et al. 2012) | |
|
| 81 | +| [DLGAP1](DLGAP1) | 2 | (Love et al. 2012) | |
|
| 82 | +| [DNMT1](DNMT1) | 2 | (Panea et al. 2019) | |
|
| 83 | +| [DTX1](DTX1) | 2 | (Panea et al. 2019; Schmitz et al. 2018) | |
|
| 84 | +| [E2F2](E2F2) | 2 | (Burkhardt et al. 2022) | |
|
| 85 | +| [EBF1](EBF1) | 2 | \[@; Bohle et al. (2013)\] | |
|
| 86 | +| [EDNRB](EDNRB) | 2 | (Burkhardt et al. 2022) | |
|
| 87 | +| [EHD1](EHD1) | 2 | \[@\] | |
|
| 88 | +| [EIF2C4](EIF2C4) | 2 | (Love et al. 2012) | |
|
| 89 | +| [ELP2](ELP2) | 2 | (Schmitz et al. 2012) | |
|
| 90 | +| [EML2](EML2) | 2 | (Love et al. 2012) | |
|
| 91 | +| [ENTPD3](ENTPD3) | 2 | (Love et al. 2012) | |
|
| 92 | +| [EP300](EP300) | 2 | \[@; Laura Pasqualucci, Dominguez-Sola, et al. (2011); Laura Pasqualucci, Dominguez-Sola, et al. (2011)\] | |
|
| 93 | +| [EPHB2](EPHB2) | 2 | (Love et al. 2012) | |
|
| 94 | +| [ERAP1](ERAP1) | 2 | (Burkhardt et al. 2022) | |
|
| 95 | +| [ETS1](ETS1) | 2 | (Panea et al. 2019; Morin et al. 2011) | |
|
| 96 | +| [EXOSC6](EXOSC6) | 2 | (Schmitz et al. 2012) | |
|
| 97 | +| [EZH2](EZH2) | 2 | (Love et al. 2012; Morin et al. 2010, 2010) | |
|
| 98 | +| [FAM129B](FAM129B) | 2 | (Love et al. 2012) | |
|
| 99 | +| [FGFR3](FGFR3) | 2 | (Love et al. 2012) | |
|
| 100 | +| [FLYWCH1](FLYWCH1) | 2 | (Schmitz et al. 2012) | |
|
| 101 | +| [FTCD](FTCD) | 2 | (Love et al. 2012) | |
|
| 102 | +| [FZD3](FZD3) | 2 | (Panea et al. 2019) | |
|
| 103 | +| [GGTLA4](GGTLA4) | 2 | (Love et al. 2012) | |
|
| 104 | +| [GRB2](GRB2) | 2 | (Panea et al. 2019; Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 105 | +| [GRIK5](GRIK5) | 2 | (Love et al. 2012) | |
|
| 106 | +| [GTSE1](GTSE1) | 2 | (Schmitz et al. 2012) | |
|
| 107 | +| [HIST1H1B](HIST1H1B) | 2 | (Krysiak et al. 2017; Chapuy et al. 2018) | |
|
| 108 | +| [HIST1H1C](HIST1H1C) | 2 | (Panea et al. 2019; Morin et al. 2011, 2011) | |
|
| 109 | +| [HIST1H1D](HIST1H1D) | 2 | (Krysiak et al. 2017; Morin et al. 2013) | |
|
| 110 | +| [HIST1H1E](HIST1H1E) | 2 | (Grande et al. 2019; Krysiak et al. 2017; Morin et al. 2013) | |
|
| 111 | +| [HIST1H2AG](HIST1H2AG) | 2 | (Panea et al. 2019; Krysiak et al. 2017; Morin et al. 2013) | |
|
| 112 | +| [HIST1H2AM](HIST1H2AM) | 2 | (Panea et al. 2019; Krysiak et al. 2017) | |
|
| 113 | +| [HIST1H2BK](HIST1H2BK) | 2 | (Panea et al. 2019) | |
|
| 114 | +| [HIST1H3D](HIST1H3D) | 2 | (Panea et al. 2019) | |
|
| 115 | +| [HIST1H3H](HIST1H3H) | 2 | (Panea et al. 2019) | |
|
| 116 | +| [HIST1H3I](HIST1H3I) | 2 | (Panea et al. 2019; Krysiak et al. 2017) | |
|
| 117 | +| [HIST1H3J](HIST1H3J) | 2 | (Panea et al. 2019) | |
|
| 118 | +| [HIST1H4J](HIST1H4J) | 2 | (Panea et al. 2019) | |
|
| 119 | +| [HLA-A](HLA-A) | 2 | \[@\] | |
|
| 120 | +| [HLA-B](HLA-B) | 2 | \[@\] | |
|
| 121 | +| [HLA-DMB](HLA-DMB) | 2 | \[@\] | |
|
| 122 | +| [HLA-DQB1](HLA-DQB1) | 2 | (Burkhardt et al. 2022) | |
|
| 123 | +| [ICK](ICK) | 2 | (Love et al. 2012) | |
|
| 124 | +| [IGLL5](IGLL5) | 2 | (Panea et al. 2019; Russler-Germain et al. 2023) | |
|
| 125 | +| [IKZF3](IKZF3) | 2 | (Panea et al. 2019; Morin et al. 2013) | |
|
| 126 | +| [IRF8](IRF8) | 2 | (Panea et al. 2019; Morin et al. 2011, 2011) | |
|
| 127 | +| [ITPR3](ITPR3) | 2 | (Love et al. 2012) | |
|
| 128 | +| [KANK2](KANK2) | 2 | (Schmitz et al. 2012) | |
|
| 129 | +| [KCNK10](KCNK10) | 2 | (Panea et al. 2019) | |
|
| 130 | +| [KIFC3](KIFC3) | 2 | (Love et al. 2012) | |
|
| 131 | +| [KLHL26](KLHL26) | 2 | (Burkhardt et al. 2022) | |
|
| 132 | +| [KLHL6](KLHL6) | 2 | \[@; Morin et al. (2011); Morin et al. (2011)\] | |
|
| 133 | +| [KMT2C](KMT2C) | 2 | (Zhou et al. 2019; Zhang et al. 2013) | |
|
| 134 | +| [LCOR](LCOR) | 2 | \[@; Arthur et al. (2018)\] | |
|
| 135 | +| [LTB](LTB) | 2 | \[@; Chapuy et al. (2018)\] | |
|
| 136 | +| [MAP3K6](MAP3K6) | 2 | (Love et al. 2012) | |
|
| 137 | +| [MCL1](MCL1) | 2 | (Panea et al. 2019; Reddy et al. 2017) | |
|
| 138 | +| [MEF2B](MEF2B) | 2 | \[@; Morin et al. (2011); Morin et al. (2011)\] | |
|
| 139 | +| [MIR142](MIR142) | 2 | (Grande et al. 2019; Kwanhian et al. 2012) | |
|
| 140 | +| [MKI67](MKI67) | 2 | (Schmitz et al. 2012; Russler-Germain et al. 2023) | |
|
| 141 | +| [MME](MME) | 2 | (Panea et al. 2019) | |
|
| 142 | +| [MTOR](MTOR) | 2 | (Panea et al. 2019; Zhang et al. 2013) | |
|
| 143 | +| [MYH10](MYH10) | 2 | (Love et al. 2012) | |
|
| 144 | +| [MYO18A](MYO18A) | 2 | (Schmitz et al. 2012) | |
|
| 145 | +| [NBEAL1](NBEAL1) | 2 | (Love et al. 2012) | |
|
| 146 | +| [NCOR2](NCOR2) | 2 | (Schmitz et al. 2012) | |
|
| 147 | +| [NOA1](NOA1) | 2 | (Burkhardt et al. 2022) | |
|
| 148 | +| [NOTCH1](NOTCH1) | 2 | (Love et al. 2012; Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 149 | +| [NOTCH2](NOTCH2) | 2 | (Panea et al. 2019; Trøen et al. 2008) | |
|
| 150 | +| [NRXN2](NRXN2) | 2 | (Love et al. 2012) | |
|
| 151 | +| [P2RY2](P2RY2) | 2 | (Love et al. 2012) | |
|
| 152 | +| [PABPC4L](PABPC4L) | 2 | (Panea et al. 2019) | |
|
| 153 | +| [PC](PC) | 2 | (Love et al. 2012) | |
|
| 154 | +| [PCBP1](PCBP1) | 2 | (Schmitz et al. 2012) | |
|
| 155 | +| [PCDHA11](PCDHA11) | 2 | (Panea et al. 2019) | |
|
| 156 | +| [PDCD11](PDCD11) | 2 | (Schmitz et al. 2012) | |
|
| 157 | +| [PDZRN3](PDZRN3) | 2 | (Panea et al. 2019) | |
|
| 158 | +| [PIK3R1](PIK3R1) | 2 | (Panea et al. 2019; Zhang et al. 2013) | |
|
| 159 | +| [PIM1](PIM1) | 2 | (Burkhardt et al. 2022; L. Pasqualucci et al. 2001) | |
|
| 160 | +| [PLCG2](PLCG2) | 2 | (Panea et al. 2019) | |
|
| 161 | +| [PMAIP1](PMAIP1) | 2 | \[@\] | |
|
| 162 | +| [POLRMT](POLRMT) | 2 | (Love et al. 2012) | |
|
| 163 | +| [POR](POR) | 2 | (Love et al. 2012) | |
|
| 164 | +| [PPP6R2](PPP6R2) | 2 | (Burkhardt et al. 2022) | |
|
| 165 | +| [PRDM1](PRDM1) | 2 | \[@; (**pasqualucciInactivationPRDM1BLIMP12006?**)\] | |
|
| 166 | +| [PREX1](PREX1) | 2 | (Burkhardt et al. 2022) | |
|
| 167 | +| [PRKCD](PRKCD) | 2 | \[@\] | |
|
| 168 | +| [PRSS22](PRSS22) | 2 | (Love et al. 2012) | |
|
| 169 | +| [PTPRN](PTPRN) | 2 | (Love et al. 2012) | |
|
| 170 | +| [PXDNL](PXDNL) | 2 | (Panea et al. 2019) | |
|
| 171 | +| [RAC2](RAC2) | 2 | (Panea et al. 2019; Hübschmann et al. 2021) | |
|
| 172 | +| [RANBP6](RANBP6) | 2 | (Love et al. 2012) | |
|
| 173 | +| [RBP3](RBP3) | 2 | (Love et al. 2012) | |
|
| 174 | +| [RET](RET) | 2 | (Love et al. 2012) | |
|
| 175 | +| [REV3L](REV3L) | 2 | (Burkhardt et al. 2022) | |
|
| 176 | +| [RNF144B](RNF144B) | 2 | (Panea et al. 2019) | |
|
| 177 | +| [RPL10](RPL10) | 2 | (Burkhardt et al. 2022) | |
|
| 178 | +| [RPL22](RPL22) | 2 | \[@\] | |
|
| 179 | +| [S1PR2](S1PR2) | 2 | (Muppidi et al. 2014; Morin et al. 2011) | |
|
| 180 | +| [SAL3](SAL3) | 2 | (Burkhardt et al. 2022) | |
|
| 181 | +| [SALL3](SALL3) | 2 | (Love et al. 2012) | |
|
| 182 | +| [SAPS2](SAPS2) | 2 | (Love et al. 2012) | |
|
| 183 | +| [SBF1](SBF1) | 2 | (Love et al. 2012) | |
|
| 184 | +| [SEPT10](SEPT10) | 2 | \[@\] | |
|
| 185 | +| [SF3B1](SF3B1) | 2 | (Love et al. 2012) | |
|
| 186 | +| [SHANK1](SHANK1) | 2 | (Love et al. 2012) | |
|
| 187 | +| [SLC29A2](SLC29A2) | 2 | (Love et al. 2012) | |
|
| 188 | +| [SNTB2](SNTB2) | 2 | (Panea et al. 2019) | |
|
| 189 | +| [SP3](SP3) | 2 | (Panea et al. 2019) | |
|
| 190 | +| [SYNCRIP](SYNCRIP) | 2 | (Panea et al. 2019) | |
|
| 191 | +| [SYNGAP1](SYNGAP1) | 2 | (Love et al. 2012) | |
|
| 192 | +| [TBC1D9B](TBC1D9B) | 2 | (Love et al. 2012) | |
|
| 193 | +| [TET2](TET2) | 2 | (Panea et al. 2019; Albuquerque et al. 2017) | |
|
| 194 | +| [TIGD6](TIGD6) | 2 | (Love et al. 2012) | |
|
| 195 | +| [TOP2A](TOP2A) | 2 | (Schmitz et al. 2012) | |
|
| 196 | +| [TPST2](TPST2) | 2 | (Love et al. 2012) | |
|
| 197 | +| [TTN](TTN) | 2 | (Burkhardt et al. 2022) | |
|
| 198 | +| [VWA7](VWA7) | 2 | (Burkhardt et al. 2022) | |
|
| 199 | +| [WDR7](WDR7) | 2 | (Panea et al. 2019) | |
|
| 200 | +| [WDR90](WDR90) | 2 | (Schmitz et al. 2012) | |
|
| 201 | +| [WHAMM](WHAMM) | 2 | (Schmitz et al. 2012) | |
|
| 202 | +| [WNK2](WNK2) | 2 | (Panea et al. 2019) | |
|
| 203 | +| [YY1AP1](YY1AP1) | 2 | (Schmitz et al. 2012) | |
|
| 204 | +| [ZAN](ZAN) | 2 | (Burkhardt et al. 2022) | |
|
| 205 | +| [ZBTB7A](ZBTB7A) | 2 | (Burkhardt et al. 2022; Reddy et al. 2017) | |
|
| 206 | +| [ZFP36L1](ZFP36L1) | 2 | (Panea et al. 2019; Morin et al. 2011) | |
|
| 207 | +| [ZNF229](ZNF229) | 2 | (Love et al. 2012) | |
|
| 208 | +| [ZNF85](ZNF85) | 2 | (Burkhardt et al. 2022) | |
|
| 209 | + |
|
| 210 | +# References |
|
| 211 | + |
|
| 212 | +<div id="refs" class="references csl-bib-body hanging-indent"> |
|
| 213 | + |
|
| 214 | +<div id="ref-abateDistinctViralMutational2015a" class="csl-entry"> |
|
| 215 | + |
|
| 216 | +Abate, F., M. Ambrosio, L. Mundo, M. Laginestra, F. Fuligni, M. Rossi, |
|
| 217 | +Sakellarios Zairis, et al. 2015. “Distinct Viral and Mutational Spectrum |
|
| 218 | +of Endemic Burkitt Lymphoma.” *PLoS Pathogens* 11. |
|
| 219 | +<https://doi.org/10.1371/journal.ppat.1005158>. |
|
| 220 | + |
|
| 221 | +</div> |
|
| 222 | + |
|
| 223 | +<div id="ref-albuquerqueEnhancingKnowledgeDiscovery2017a" |
|
| 224 | +class="csl-entry"> |
|
| 225 | + |
|
| 226 | +Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath |
|
| 227 | +Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal, |
|
| 228 | +Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing |
|
| 229 | +Knowledge Discovery from Cancer Genomics Data with Galaxy.” |
|
| 230 | +*GigaScience* 6 (5): 1–13. <https://doi.org/10.1093/gigascience/gix015>. |
|
| 231 | + |
|
| 232 | +</div> |
|
| 233 | + |
|
| 234 | +<div id="ref-arthurGenomewideDiscoverySomatic2018" class="csl-entry"> |
|
| 235 | + |
|
| 236 | +Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan |
|
| 237 | +Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide |
|
| 238 | +Discovery of Somatic Regulatory Variants in Diffuse Large <span |
|
| 239 | +class="nocase">B-cell</span> Lymphoma.” *Nature Communications* 9 (1): |
|
| 240 | +4001. <https://doi.org/10.1038/s41467-018-06354-3>. |
|
| 241 | + |
|
| 242 | +</div> |
|
| 243 | + |
|
| 244 | +<div id="ref-bohleRoleEarlyBcell2013" class="csl-entry"> |
|
| 245 | + |
|
| 246 | +Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of |
|
| 247 | +Early <span class="nocase">B-cell</span> Factor 1 (EBF1) in Hodgkin |
|
| 248 | +Lymphoma.” *Leukemia* 27 (3): 671–79. |
|
| 249 | +<https://doi.org/10.1038/leu.2012.280>. |
|
| 250 | + |
|
| 251 | +</div> |
|
| 252 | + |
|
| 253 | +<div id="ref-burkhardtClinicalRelevanceMolecular2022b" |
|
| 254 | +class="csl-entry"> |
|
| 255 | + |
|
| 256 | +Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp |
|
| 257 | +Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance |
|
| 258 | +of Molecular Characteristics in Burkitt Lymphoma Differs According to |
|
| 259 | +Age.” *Nature Communications* 13 (1): 3881. |
|
| 260 | +<https://doi.org/10.1038/s41467-022-31355-8>. |
|
| 261 | + |
|
| 262 | +</div> |
|
| 263 | + |
|
| 264 | +<div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry"> |
|
| 265 | + |
|
| 266 | +Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas |
|
| 267 | +Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular |
|
| 268 | +Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct |
|
| 269 | +Pathogenic Mechanisms and Outcomes.” *Nature Medicine* 24 (5): 679–90. |
|
| 270 | +<https://doi.org/10.1038/s41591-018-0016-8>. |
|
| 271 | + |
|
| 272 | +</div> |
|
| 273 | + |
|
| 274 | +<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry"> |
|
| 275 | + |
|
| 276 | +Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, |
|
| 277 | +Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019. |
|
| 278 | +“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in |
|
| 279 | +Pediatric Endemic and Sporadic Burkitt Lymphoma.” *Blood* 133 (12): |
|
| 280 | +1313–24. <https://doi.org/10.1182/blood-2018-09-871418>. |
|
| 281 | + |
|
| 282 | +</div> |
|
| 283 | + |
|
| 284 | +<div id="ref-hubschmannMutationalMechanismsShaping2021b" |
|
| 285 | +class="csl-entry"> |
|
| 286 | + |
|
| 287 | +Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. |
|
| 288 | +Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. |
|
| 289 | +2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of |
|
| 290 | +Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
|
| 291 | +*Leukemia* 35 (7): 2002–16. |
|
| 292 | +<https://doi.org/10.1038/s41375-021-01251-z>. |
|
| 293 | + |
|
| 294 | +</div> |
|
| 295 | + |
|
| 296 | +<div id="ref-johnstonCmycHypermutationBurkitt1992" class="csl-entry"> |
|
| 297 | + |
|
| 298 | +Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in |
|
| 299 | +Burkitt’s Lymphoma.” *Leukemia & Lymphoma* 8 (6): 431–39. |
|
| 300 | +<https://doi.org/10.3109/10428199209051025>. |
|
| 301 | + |
|
| 302 | +</div> |
|
| 303 | + |
|
| 304 | +<div id="ref-khodabakhshiRecurrentTargetsAberrant2012" |
|
| 305 | +class="csl-entry"> |
|
| 306 | + |
|
| 307 | +Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J. |
|
| 308 | +Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et |
|
| 309 | +al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in |
|
| 310 | +Lymphoma.” *Oncotarget* 3 (11): 1308–19. |
|
| 311 | +<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/>. |
|
| 312 | + |
|
| 313 | +</div> |
|
| 314 | + |
|
| 315 | +<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry"> |
|
| 316 | + |
|
| 317 | +Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, |
|
| 318 | +Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. |
|
| 319 | +“Recurrent Somatic Mutations Affecting <span |
|
| 320 | +class="nocase">B-cell</span> Receptor Signaling Pathway Genes in |
|
| 321 | +Follicular Lymphoma.” *Blood* 129 (4): 473–83. |
|
| 322 | +<https://doi.org/10.1182/blood-2016-07-729954>. |
|
| 323 | + |
|
| 324 | +</div> |
|
| 325 | + |
|
| 326 | +<div id="ref-kwanhianMicroRNA142Mutated202012b" class="csl-entry"> |
|
| 327 | + |
|
| 328 | +Kwanhian, Wiyada, Dido Lenze, Julia Alles, Natalie Motsch, Stephanie |
|
| 329 | +Barth, Celina Döll, Jochen Imig, et al. 2012. “MicroRNA-142 Is Mutated |
|
| 330 | +in about 20% of Diffuse Large <span class="nocase">B-cell</span> |
|
| 331 | +Lymphoma.” *Cancer Medicine* 1 (2): 141–55. |
|
| 332 | +<https://doi.org/10.1002/cam4.29>. |
|
| 333 | + |
|
| 334 | +</div> |
|
| 335 | + |
|
| 336 | +<div id="ref-lenzOncogenicCARD11Mutations2008" class="csl-entry"> |
|
| 337 | + |
|
| 338 | +Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, |
|
| 339 | +George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11 |
|
| 340 | +Mutations in Human Diffuse Large B Cell Lymphoma.” *Science* 319 (5870): |
|
| 341 | +1676–79. |
|
| 342 | + |
|
| 343 | +</div> |
|
| 344 | + |
|
| 345 | +<div id="ref-lohrDiscoveryPrioritizationSomatic2012a" class="csl-entry"> |
|
| 346 | + |
|
| 347 | +Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair, |
|
| 348 | +Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012. |
|
| 349 | +“Discovery and Prioritization of Somatic Mutations in Diffuse Large |
|
| 350 | +<span class="nocase">B-cell</span> Lymphoma (DLBCL) by Whole-Exome |
|
| 351 | +Sequencing.” *Proceedings of the National Academy of Sciences of the |
|
| 352 | +United States of America* 109 (10): 3879–84. |
|
| 353 | +<https://doi.org/10.1073/pnas.1121343109>. |
|
| 354 | + |
|
| 355 | +</div> |
|
| 356 | + |
|
| 357 | +<div id="ref-loveGeneticLandscapeMutations2012" class="csl-entry"> |
|
| 358 | + |
|
| 359 | +Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney |
|
| 360 | +Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of |
|
| 361 | +Mutations in Burkitt Lymphoma.” *Nature Genetics* 44 (12): 1321–25. |
|
| 362 | +<https://doi.org/10.1038/ng.2468>. |
|
| 363 | + |
|
| 364 | +</div> |
|
| 365 | + |
|
| 366 | +<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry"> |
|
| 367 | + |
|
| 368 | +Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. |
|
| 369 | +Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. |
|
| 370 | +“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse |
|
| 371 | +Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center |
|
| 372 | +Origin.” *Nature Genetics* 42 (2): 181–85. |
|
| 373 | +<https://doi.org/10.1038/ng.518>. |
|
| 374 | + |
|
| 375 | +</div> |
|
| 376 | + |
|
| 377 | +<div id="ref-morinFrequentMutationHistonemodifying2011" |
|
| 378 | +class="csl-entry"> |
|
| 379 | + |
|
| 380 | +Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, |
|
| 381 | +Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. |
|
| 382 | +“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” |
|
| 383 | +*Nature* 476 (7360): 298–303. <https://doi.org/10.1038/nature10351>. |
|
| 384 | + |
|
| 385 | +</div> |
|
| 386 | + |
|
| 387 | +<div id="ref-morinMutationalStructuralAnalysis2013" class="csl-entry"> |
|
| 388 | + |
|
| 389 | +Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, |
|
| 390 | +Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and |
|
| 391 | +Structural Analysis of Diffuse Large <span class="nocase">B-cell</span> |
|
| 392 | +Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 (7): 1256–65. |
|
| 393 | +<https://doi.org/10.1182/blood-2013-02-483727>. |
|
| 394 | + |
|
| 395 | +</div> |
|
| 396 | + |
|
| 397 | +<div id="ref-muppidiLossSignalingGa132014b" class="csl-entry"> |
|
| 398 | + |
|
| 399 | +Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao, |
|
| 400 | +Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in |
|
| 401 | +Germinal Center B Cell-Derived Lymphoma.” *Nature* 516: 254–58. |
|
| 402 | +<https://doi.org/10.1038/nature13765>. |
|
| 403 | + |
|
| 404 | +</div> |
|
| 405 | + |
|
| 406 | +<div id="ref-paneaWholeGenomeLandscape2019" class="csl-entry"> |
|
| 407 | + |
|
| 408 | +Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A. |
|
| 409 | +Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt |
|
| 410 | +Lymphoma Subtypes.” *Blood*. <https://doi.org/10.1182/blood.2019001880>. |
|
| 411 | + |
|
| 412 | +</div> |
|
| 413 | + |
|
| 414 | +<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a" |
|
| 415 | +class="csl-entry"> |
|
| 416 | + |
|
| 417 | +Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia |
|
| 418 | +Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. |
|
| 419 | +“Inactivating Mutations of Acetyltransferase Genes in <span |
|
| 420 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 471 (7337): 189–95. |
|
| 421 | +<https://doi.org/10.1038/nature09730>. |
|
| 422 | + |
|
| 423 | +</div> |
|
| 424 | + |
|
| 425 | +<div id="ref-pasqualucciAnalysisCodingGenome2011" class="csl-entry"> |
|
| 426 | + |
|
| 427 | +Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide |
|
| 428 | +Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of |
|
| 429 | +the Coding Genome of Diffuse Large <span class="nocase">B-cell</span> |
|
| 430 | +Lymphoma.” *Nature Genetics* 43 (9): 830–37. |
|
| 431 | +<https://doi.org/10.1038/ng.892>. |
|
| 432 | + |
|
| 433 | +</div> |
|
| 434 | + |
|
| 435 | +<div id="ref-pasqualucciHypermutationMultipleProtooncogenes2001a" |
|
| 436 | +class="csl-entry"> |
|
| 437 | + |
|
| 438 | +Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S. |
|
| 439 | +Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of |
|
| 440 | +Multiple Proto-Oncogenes in <span class="nocase">B-cell</span> Diffuse |
|
| 441 | +Large-Cell Lymphomas.” *Nature* 412 (6844): 341–46. |
|
| 442 | +<https://doi.org/10.1038/35085588>. |
|
| 443 | + |
|
| 444 | +</div> |
|
| 445 | + |
|
| 446 | +<div id="ref-reddyGeneticFunctionalDrivers2017" class="csl-entry"> |
|
| 447 | + |
|
| 448 | +Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, |
|
| 449 | +Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic |
|
| 450 | +and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171 |
|
| 451 | +(2): 481–494.e15. |
|
| 452 | + |
|
| 453 | +</div> |
|
| 454 | + |
|
| 455 | +<div id="ref-richterRecurrentMutationID32012a" class="csl-entry"> |
|
| 456 | + |
|
| 457 | +Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen |
|
| 458 | +Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent |
|
| 459 | +Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated |
|
| 460 | +Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 (12): |
|
| 461 | +1316–20. <https://doi.org/10.1038/ng.2469>. |
|
| 462 | + |
|
| 463 | +</div> |
|
| 464 | + |
|
| 465 | +<div id="ref-russler-germainMutationsAssociatedProgression2023b" |
|
| 466 | +class="csl-entry"> |
|
| 467 | + |
|
| 468 | +Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew |
|
| 469 | +Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. |
|
| 470 | +2023. “Mutations Associated with Progression in Follicular Lymphoma |
|
| 471 | +Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood |
|
| 472 | +Advances* 7: 5524–39. |
|
| 473 | +<https://doi.org/10.1182/bloodadvances.2023010779>. |
|
| 474 | + |
|
| 475 | +</div> |
|
| 476 | + |
|
| 477 | +<div id="ref-schmitzGeneticsPathogenesisDiffuse2018a" class="csl-entry"> |
|
| 478 | + |
|
| 479 | +Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson, |
|
| 480 | +James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018. |
|
| 481 | +“Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” *The New |
|
| 482 | +England Journal of Medicine* 378 (15): 1396–1407. |
|
| 483 | +<https://doi.org/10.1056/NEJMoa1801445>. |
|
| 484 | + |
|
| 485 | +</div> |
|
| 486 | + |
|
| 487 | +<div id="ref-schmitzBurkittLymphomaPathogenesis2012" class="csl-entry"> |
|
| 488 | + |
|
| 489 | +Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, |
|
| 490 | +Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma |
|
| 491 | +Pathogenesis and Therapeutic Targets from Structural and Functional |
|
| 492 | +Genomics.” *Nature* 490 (7418): 116–20. |
|
| 493 | +<https://doi.org/10.1038/nature11378>. |
|
| 494 | + |
|
| 495 | +</div> |
|
| 496 | + |
|
| 497 | +<div id="ref-tanakaFrequentIncidenceSomatic1992" class="csl-entry"> |
|
| 498 | + |
|
| 499 | +Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent |
|
| 500 | +Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of |
|
| 501 | +Non-Hodgkin’s Lymphomas.” *Blood* 79 (1): 229–37. |
|
| 502 | + |
|
| 503 | +</div> |
|
| 504 | + |
|
| 505 | +<div id="ref-thomasGeneticSubgroupsInform2023" class="csl-entry"> |
|
| 506 | + |
|
| 507 | +Thomas, Nicole, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, |
|
| 508 | +Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, et al. 2023. |
|
| 509 | +“Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt |
|
| 510 | +Lymphoma.” *Blood* 141 (8): 904–16. |
|
| 511 | +<https://doi.org/10.1182/blood.2022016534>. |
|
| 512 | + |
|
| 513 | +</div> |
|
| 514 | + |
|
| 515 | +<div id="ref-tiacciBRAFMutationsHairycell2011a" class="csl-entry"> |
|
| 516 | + |
|
| 517 | +Tiacci, Enrico, Vladimir Trifonov, Gianluca Schiavoni, Antony Holmes, |
|
| 518 | +Wolfgang Kern, Maria Paola Martelli, Alessandra Pucciarini, et al. 2011. |
|
| 519 | +“BRAF Mutations in Hairy-Cell Leukemia.” *The New England Journal of |
|
| 520 | +Medicine* 364 (24): 2305–15. <https://doi.org/10.1056/NEJMoa1014209>. |
|
| 521 | + |
|
| 522 | +</div> |
|
| 523 | + |
|
| 524 | +<div id="ref-troenNOTCH2MutationsMarginal2008" class="csl-entry"> |
|
| 525 | + |
|
| 526 | +Trøen, Gunhild, Iwona Wlodarska, Abdirashid Warsame, Silvia Hernández |
|
| 527 | +Llodrà, Christiane De Wolf-Peeters, and Jan Delabie. 2008. “NOTCH2 |
|
| 528 | +Mutations in Marginal Zone Lymphoma.” *Haematologica* 93 (7): 1107–9. |
|
| 529 | +<https://doi.org/10.3324/haematol.11635>. |
|
| 530 | + |
|
| 531 | +</div> |
|
| 532 | + |
|
| 533 | +<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry"> |
|
| 534 | + |
|
| 535 | +Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and |
|
| 536 | +W. Woessmann. 2004. “Inactivation of the <span |
|
| 537 | +class="nocase">ARF-MDM-2-p53</span> Pathway in Sporadic Burkitt’s |
|
| 538 | +Lymphoma in Children.” *Leukemia* 18 (3): 584–88. |
|
| 539 | +<https://doi.org/10.1038/sj.leu.2403254>. |
|
| 540 | + |
|
| 541 | +</div> |
|
| 542 | + |
|
| 543 | +<div id="ref-zhangGeneticHeterogeneityDiffuse2013" class="csl-entry"> |
|
| 544 | + |
|
| 545 | +Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, |
|
| 546 | +Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. |
|
| 547 | +“Genetic Heterogeneity of Diffuse Large <span |
|
| 548 | +class="nocase">B-cell</span> Lymphoma.” January. |
|
| 549 | + |
|
| 550 | +</div> |
|
| 551 | + |
|
| 552 | +<div id="ref-zhouSporadicEndemicBurkitt2019" class="csl-entry"> |
|
| 553 | + |
|
| 554 | +Zhou, Peixun, Alex E. Blain, Alexander M. Newman, Masood Zaka, George |
|
| 555 | +Chagaluka, Filbert R. Adlar, Ugonna T. Offor, et al. 2019. “Sporadic and |
|
| 556 | +Endemic Burkitt Lymphoma Have Frequent FOXO1 Mutations but Distinct |
|
| 557 | +Hotspots in the AKT Recognition Motif.” *Blood Advances* 3 (14): |
|
| 558 | +2118–27. <https://doi.org/10.1182/bloodadvances.2018029546>. |
|
| 559 | + |
|
| 560 | +</div> |
|
| 561 | + |
|
| 562 | +</div> |
DLBCL_genes_with_bib.md
| ... | ... | @@ -1,340 +1,342 @@ |
| 1 | 1 | # DLBCL genes |
| 2 | 2 | |
| 3 | +## Origins of DLBCL genes |
|
| 4 | + |
|
| 3 | 5 | ## Tier 1 DLBCL genes |
| 4 | 6 | |
| 5 | -| Gene | Tier | Relevant references | |
|
| 6 | -|:----------------------:|:----:|:------------------------------------------------:| |
|
| 7 | -| [ACTB](ACTB) | 1 | (Lohr et al. 2012) | |
|
| 8 | -| [ACTG1](ACTG1) | 1 | (Hübschmann et al. 2021) | |
|
| 9 | -| [ARID1A](ARID1A) | 1 | (Zhang et al. 2013; Krysiak et al. 2017) | |
|
| 10 | -| [ATM](ATM) | 1 | (Reddy et al. 2017) | |
|
| 11 | -| [B2M](B2M) | 1 | (Morin et al. 2011) | |
|
| 12 | -| [BCL10](BCL10) | 1 | (Morin et al. 2011; Russler-Germain et al. 2023) | |
|
| 13 | -| [BCL11A](BCL11A) | 1 | | |
|
| 14 | -| [BCL2](BCL2) | 1 | (Tanaka et al. 1992; Morin et al. 2011) | |
|
| 15 | -| [BCL6](BCL6) | 1 | (Morin et al. 2011) | |
|
| 16 | -| [BCL7A](BCL7A) | 1 | (Arthur et al. 2018; Krysiak et al. 2017) | |
|
| 17 | -| [BCOR](BCOR) | 1 | | |
|
| 18 | -| [BCR](BCR) | 1 | | |
|
| 19 | -| [BIRC6](BIRC6) | 1 | (Reddy et al. 2017) | |
|
| 20 | -| [BRAF](BRAF) | 1 | (Tiacci et al. 2011) | |
|
| 21 | -| [BTG1](BTG1) | 1 | (Morin et al. 2011) | |
|
| 22 | -| [BTG2](BTG2) | 1 | (Morin et al. 2011) | |
|
| 23 | -| [BTK](BTK) | 1 | (Albuquerque et al. 2017; Krysiak et al. 2017) | |
|
| 24 | -| [CARD11](CARD11) | 1 | (Lenz et al. 2008; Morin et al. 2011) | |
|
| 25 | -| [CASP8](CASP8) | 1 | (Reddy et al. 2017) | |
|
| 26 | -| [CCND3](CCND3) | 1 | (Morin et al. 2011) | |
|
| 27 | -| [CD274](CD274) | 1 | (Morin et al. 2011) | |
|
| 28 | -| [CD36](CD36) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 29 | -| [CD58](CD58) | 1 | (Morin et al. 2011) | |
|
| 30 | -| [CD70](CD70) | 1 | (Morin et al. 2011; Russler-Germain et al. 2023) | |
|
| 31 | -| [CD79B](CD79B) | 1 | (Morin et al. 2011) | |
|
| 32 | -| [CD83](CD83) | 1 | (Morin et al. 2013; Russler-Germain et al. 2023) | |
|
| 33 | -| [CDKN2A](CDKN2A) | 1 | (Morin et al. 2013) | |
|
| 34 | -| [CIITA](CIITA) | 1 | (Morin et al. 2011) | |
|
| 35 | -| [CREBBP](CREBBP) | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | |
|
| 36 | -| [CXCR4](CXCR4) | 1 | (Khodabakhshi et al. 2012; Krysiak et al. 2017) | |
|
| 37 | -| [CXCR5](CXCR5) | 1 | (Schmitz et al. 2018) | |
|
| 38 | -| [DAZAP1](DAZAP1) | 1 | (Pararajalingam et al. 2020) | |
|
| 39 | -| [DDX3X](DDX3X) | 1 | (Schmitz et al. 2018) | |
|
| 40 | -| [DTX1](DTX1) | 1 | (Schmitz et al. 2018) | |
|
| 41 | -| [DUSP2](DUSP2) | 1 | (Morin et al. 2013) | |
|
| 42 | -| [EBF1](EBF1) | 1 | (Bohle et al. 2013) | |
|
| 43 | -| [EEF1A1](EEF1A1) | 1 | (Hübschmann et al. 2021) | |
|
| 44 | -| [EP300](EP300) | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | |
|
| 45 | -| [ETS1](ETS1) | 1 | (Morin et al. 2011) | |
|
| 46 | -| [ETV6](ETV6) | 1 | (Arthur et al. 2018) | |
|
| 47 | -| [EZH2](EZH2) | 1 | (Morin et al. 2010) | |
|
| 48 | -| [FAS](FAS) | 1 | (Scholl et al. 2007) | |
|
| 49 | -| [FBXO11](FBXO11) | 1 | (Hübschmann et al. 2021) | |
|
| 50 | -| [FBXW7](FBXW7) | 1 | (Zhang et al. 2013) | |
|
| 51 | -| [FOXC1](FOXC1) | 1 | (Schmitz et al. 2018) | |
|
| 52 | -| [FOXO1](FOXO1) | 1 | (Morin et al. 2011) | |
|
| 53 | -| [GNA13](GNA13) | 1 | (Morin et al. 2011) | |
|
| 54 | -| [GNAI2](GNAI2) | 1 | (Morin et al. 2013) | |
|
| 55 | -| [GRB2](GRB2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 56 | -| [GRHPR](GRHPR) | 1 | (Arthur et al. 2018) | |
|
| 57 | -| [HIST1H1B](HIST1H1B) | 1 | (Chapuy et al. 2018; Krysiak et al. 2017) | |
|
| 58 | -| [HIST1H1C](HIST1H1C) | 1 | (Morin et al. 2011) | |
|
| 59 | -| [HIST1H1D](HIST1H1D) | 1 | (Morin et al. 2013; Krysiak et al. 2017) | |
|
| 60 | -| [HIST1H1E](HIST1H1E) | 1 | (Morin et al. 2013; Krysiak et al. 2017) | |
|
| 61 | -| [HIST1H2AC](HIST1H2AC) | 1 | (Morin et al. 2013; Krysiak et al. 2017) | |
|
| 62 | -| [HIST1H2AM](HIST1H2AM) | 1 | (Krysiak et al. 2017) | |
|
| 63 | -| [HIST1H2BC](HIST1H2BC) | 1 | (Reddy et al. 2017; Krysiak et al. 2017) | |
|
| 64 | -| [HIST1H2BK](HIST1H2BK) | 1 | | |
|
| 65 | -| [HIST1H3B](HIST1H3B) | 1 | (Zhang et al. 2013) | |
|
| 66 | -| [HIST2H2BE](HIST2H2BE) | 1 | (Schmitz et al. 2018) | |
|
| 67 | -| [HLA-A](HLA-A) | 1 | | |
|
| 68 | -| [HLA-B](HLA-B) | 1 | | |
|
| 69 | -| [HLA-C](HLA-C) | 1 | | |
|
| 70 | -| [HLA-DMA](HLA-DMA) | 1 | | |
|
| 71 | -| [HLA-DMB](HLA-DMB) | 1 | | |
|
| 72 | -| [HLA-DQA1](HLA-DQA1) | 1 | (Hübschmann et al. 2021) | |
|
| 73 | -| [HNRNPD](HNRNPD) | 1 | | |
|
| 74 | -| [HNRNPH1](HNRNPH1) | 1 | (Pararajalingam et al. 2020) | |
|
| 75 | -| [HNRNPU](HNRNPU) | 1 | (Reddy et al. 2017) | |
|
| 76 | -| [HVCN1](HVCN1) | 1 | (Krysiak et al. 2017) | |
|
| 77 | -| [IKZF3](IKZF3) | 1 | (Morin et al. 2013) | |
|
| 78 | -| [IL16](IL16) | 1 | | |
|
| 79 | -| [IL4R](IL4R) | 1 | (Duns et al. 2021) | |
|
| 80 | -| [IRF4](IRF4) | 1 | (Morin et al. 2011) | |
|
| 81 | -| [IRF8](IRF8) | 1 | (Morin et al. 2011) | |
|
| 82 | -| [ITPKB](ITPKB) | 1 | (Schmitz et al. 2018) | |
|
| 83 | -| [JUNB](JUNB) | 1 | (Reddy et al. 2017) | |
|
| 84 | -| [KLF2](KLF2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 85 | -| [KLHL14](KLHL14) | 1 | (Zhang et al. 2013) | |
|
| 86 | -| [KLHL6](KLHL6) | 1 | (Morin et al. 2011) | |
|
| 87 | -| [KMT2C](KMT2C) | 1 | (Zhang et al. 2013) | |
|
| 88 | -| [KMT2D](KMT2D) | 1 | (Morin et al. 2011) | |
|
| 89 | -| [KRAS](KRAS) | 1 | (Lohr et al. 2012) | |
|
| 90 | -| [LCOR](LCOR) | 1 | (Arthur et al. 2018) | |
|
| 91 | -| [LTB](LTB) | 1 | (Chapuy et al. 2018) | |
|
| 92 | -| [LYN](LYN) | 1 | (Chapuy et al. 2018) | |
|
| 93 | -| [MCL1](MCL1) | 1 | (Reddy et al. 2017) | |
|
| 94 | -| [MEF2B](MEF2B) | 1 | (Morin et al. 2011) | |
|
| 95 | -| [MEF2C](MEF2C) | 1 | (Arthur et al. 2018) | |
|
| 96 | -| [MGA](MGA) | 1 | (Zhang et al. 2013) | |
|
| 97 | -| [MPEG1](MPEG1) | 1 | (Morin et al. 2013) | |
|
| 98 | -| [MS4A1](MS4A1) | 1 | (Rushton et al. 2020) | |
|
| 99 | -| [MTOR](MTOR) | 1 | (Zhang et al. 2013) | |
|
| 100 | -| [MYC](MYC) | 1 | (L. Pasqualucci et al. 2001) | |
|
| 101 | -| [MYD88](MYD88) | 1 | (Ngo et al. 2011) | |
|
| 102 | -| [MYOM2](MYOM2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 103 | -| [NCOR2](NCOR2) | 1 | | |
|
| 104 | -| [NFKB1](NFKB1) | 1 | | |
|
| 105 | -| [NFKBIA](NFKBIA) | 1 | (Lake et al. 2009; Russler-Germain et al. 2023) | |
|
| 106 | -| [NFKBIE](NFKBIE) | 1 | (Morin et al. 2016) | |
|
| 107 | -| [NFKBIZ](NFKBIZ) | 1 | (Morin et al. 2016) | |
|
| 108 | -| [NLRC5](NLRC5) | 1 | | |
|
| 109 | -| [NOL9](NOL9) | 1 | (Schmitz et al. 2018) | |
|
| 110 | -| [NOTCH1](NOTCH1) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 111 | -| [NOTCH2](NOTCH2) | 1 | (Trøen et al. 2008) | |
|
| 112 | -| [OSBPL10](OSBPL10) | 1 | (Arthur et al. 2018) | |
|
| 113 | -| [P2RY8](P2RY8) | 1 | (Lohr et al. 2012) | |
|
| 114 | -| [PCBP1](PCBP1) | 1 | | |
|
| 115 | -| [PIM1](PIM1) | 1 | (L. Pasqualucci et al. 2001) | |
|
| 116 | -| [PIM2](PIM2) | 1 | (Arthur et al. 2018) | |
|
| 117 | -| [POU2AF1](POU2AF1) | 1 | (Krysiak et al. 2017) | |
|
| 118 | -| [POU2F2](POU2F2) | 1 | (Zhang et al. 2013; Krysiak et al. 2017) | |
|
| 119 | -| [PRDM1](PRDM1) | 1 | (**pasqualucciInactivationPRDM1BLIMP12006?**) | |
|
| 120 | -| [PRKDC](PRKDC) | 1 | (Schmitz et al. 2018; Hübschmann et al. 2021) | |
|
| 121 | -| [PTEN](PTEN) | 1 | | |
|
| 122 | -| [PTPRD](PTPRD) | 1 | | |
|
| 123 | -| [RB1](RB1) | 1 | (Morin et al. 2013) | |
|
| 124 | -| [RFX7](RFX7) | 1 | | |
|
| 125 | -| [RFXAP](RFXAP) | 1 | | |
|
| 126 | -| [RHOA](RHOA) | 1 | (L. Pasqualucci et al. 2001) | |
|
| 127 | -| [RRAGC](RRAGC) | 1 | (Okosun et al. 2016) | |
|
| 128 | -| [S1PR2](S1PR2) | 1 | (Morin et al. 2011) | |
|
| 129 | -| [SETD1B](SETD1B) | 1 | (Reddy et al. 2017) | |
|
| 130 | -| [SF3B1](SF3B1) | 1 | | |
|
| 131 | -| [SGK1](SGK1) | 1 | (Morin et al. 2011) | |
|
| 132 | -| [SIN3A](SIN3A) | 1 | | |
|
| 133 | -| [SMARCA4](SMARCA4) | 1 | (Zhang et al. 2013; Krysiak et al. 2017) | |
|
| 134 | -| [SOCS1](SOCS1) | 1 | (Morin et al. 2011) | |
|
| 135 | -| [SPEN](SPEN) | 1 | (Rossi et al. 2012) | |
|
| 136 | -| [STAT3](STAT3) | 1 | (Ohgami et al. 2014) | |
|
| 137 | -| [STAT6](STAT6) | 1 | (Yildiz et al. 2015) | |
|
| 138 | -| [TAF1](TAF1) | 1 | (Morin et al. 2013) | |
|
| 139 | -| [TBL1XR1](TBL1XR1) | 1 | (Mareschal et al. 2016) | |
|
| 140 | -| [TET2](TET2) | 1 | (Albuquerque et al. 2017) | |
|
| 141 | -| [TMEM30A](TMEM30A) | 1 | (Morin et al. 2011) | |
|
| 142 | -| [TMSB4X](TMSB4X) | 1 | (Albuquerque et al. 2017) | |
|
| 143 | -| [TNFAIP3](TNFAIP3) | 1 | (Compagno et al. 2009) | |
|
| 144 | -| [TNFRSF14](TNFRSF14) | 1 | (Cheung et al. 2010) | |
|
| 145 | -| [TOX](TOX) | 1 | (Reddy et al. 2017) | |
|
| 146 | -| [TP53](TP53) | 1 | (Morin et al. 2011) | |
|
| 147 | -| [TRIP12](TRIP12) | 1 | | |
|
| 148 | -| [TRRAP](TRRAP) | 1 | (Parry et al. 2013) | |
|
| 149 | -| [UBE2A](UBE2A) | 1 | (Reddy et al. 2017) | |
|
| 150 | -| [UNC5C](UNC5C) | 1 | | |
|
| 151 | -| [USP7](USP7) | 1 | | |
|
| 152 | -| [VPS13B](VPS13B) | 1 | | |
|
| 153 | -| [WEE1](WEE1) | 1 | (Schmitz et al. 2018) | |
|
| 154 | -| [XPO1](XPO1) | 1 | (Mareschal et al. 2016) | |
|
| 155 | -| [ZC3H12A](ZC3H12A) | 1 | (Arthur et al. 2018) | |
|
| 156 | -| [ZFP36L1](ZFP36L1) | 1 | (Morin et al. 2011) | |
|
| 157 | -| [ZNF292](ZNF292) | 1 | (Zhang et al. 2013) | |
|
| 158 | -| [ZNF608](ZNF608) | 1 | (Zhang et al. 2013; Krysiak et al. 2017) | |
|
| 7 | +| Gene | Tier | Relevant references | |
|
| 8 | +|:----------------------:|:----:|:-------------------------------------------------------------------:| |
|
| 9 | +| [ACTB](ACTB) | 1 | (Lohr et al. 2012) | |
|
| 10 | +| [ACTG1](ACTG1) | 1 | (Hübschmann et al. 2021) | |
|
| 11 | +| [ARID1A](ARID1A) | 1 | (Zhang et al. 2013; Krysiak et al. 2017; Love et al. 2012) | |
|
| 12 | +| [ATM](ATM) | 1 | (Reddy et al. 2017) | |
|
| 13 | +| [B2M](B2M) | 1 | (Morin et al. 2011) | |
|
| 14 | +| [BCL10](BCL10) | 1 | (Morin et al. 2011; Russler-Germain et al. 2023) | |
|
| 15 | +| [BCL11A](BCL11A) | 1 | | |
|
| 16 | +| [BCL2](BCL2) | 1 | (Tanaka et al. 1992; Morin et al. 2011; Burkhardt et al. 2022) | |
|
| 17 | +| [BCL6](BCL6) | 1 | (Morin et al. 2011; Love et al. 2012) | |
|
| 18 | +| [BCL7A](BCL7A) | 1 | (Arthur et al. 2018; Krysiak et al. 2017; Grande et al. 2019) | |
|
| 19 | +| [BCOR](BCOR) | 1 | | |
|
| 20 | +| [BCR](BCR) | 1 | | |
|
| 21 | +| [BIRC6](BIRC6) | 1 | (Reddy et al. 2017) | |
|
| 22 | +| [BRAF](BRAF) | 1 | (Tiacci et al. 2011; Love et al. 2012) | |
|
| 23 | +| [BTG1](BTG1) | 1 | (Morin et al. 2011; Burkhardt et al. 2022) | |
|
| 24 | +| [BTG2](BTG2) | 1 | (Morin et al. 2011; Love et al. 2012) | |
|
| 25 | +| [BTK](BTK) | 1 | (Albuquerque et al. 2017; Krysiak et al. 2017) | |
|
| 26 | +| [CARD11](CARD11) | 1 | (Lenz et al. 2008; Morin et al. 2011; Panea et al. 2019) | |
|
| 27 | +| [CASP8](CASP8) | 1 | (Reddy et al. 2017) | |
|
| 28 | +| [CCND3](CCND3) | 1 | (Morin et al. 2011; Richter et al. 2012) | |
|
| 29 | +| [CD274](CD274) | 1 | (Morin et al. 2011) | |
|
| 30 | +| [CD36](CD36) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 31 | +| [CD58](CD58) | 1 | (Morin et al. 2011) | |
|
| 32 | +| [CD70](CD70) | 1 | (Morin et al. 2011; Russler-Germain et al. 2023) | |
|
| 33 | +| [CD79B](CD79B) | 1 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 34 | +| [CD83](CD83) | 1 | (Morin et al. 2013; Russler-Germain et al. 2023; Panea et al. 2019) | |
|
| 35 | +| [CDKN2A](CDKN2A) | 1 | (Morin et al. 2013; Grande et al. 2019) | |
|
| 36 | +| [CIITA](CIITA) | 1 | (Morin et al. 2011) | |
|
| 37 | +| [CREBBP](CREBBP) | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011; Love et al. 2012) | |
|
| 38 | +| [CXCR4](CXCR4) | 1 | (Khodabakhshi et al. 2012; Krysiak et al. 2017; Panea et al. 2019) | |
|
| 39 | +| [CXCR5](CXCR5) | 1 | (Schmitz et al. 2018) | |
|
| 40 | +| [DAZAP1](DAZAP1) | 1 | (Pararajalingam et al. 2020) | |
|
| 41 | +| [DDX3X](DDX3X) | 1 | (Schmitz et al. 2018, 2012) | |
|
| 42 | +| [DTX1](DTX1) | 1 | (Schmitz et al. 2018; Panea et al. 2019) | |
|
| 43 | +| [DUSP2](DUSP2) | 1 | (Morin et al. 2013) | |
|
| 44 | +| [EBF1](EBF1) | 1 | \[Bohle et al. (2013); @\] | |
|
| 45 | +| [EEF1A1](EEF1A1) | 1 | (Hübschmann et al. 2021) | |
|
| 46 | +| [EP300](EP300) | 1 | \[Laura Pasqualucci, Dominguez-Sola, et al. (2011); @\] | |
|
| 47 | +| [ETS1](ETS1) | 1 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 48 | +| [ETV6](ETV6) | 1 | (Arthur et al. 2018) | |
|
| 49 | +| [EZH2](EZH2) | 1 | (Morin et al. 2010; Love et al. 2012) | |
|
| 50 | +| [FAS](FAS) | 1 | (Scholl et al. 2007) | |
|
| 51 | +| [FBXO11](FBXO11) | 1 | (Hübschmann et al. 2021; Richter et al. 2012) | |
|
| 52 | +| [FBXW7](FBXW7) | 1 | (Zhang et al. 2013) | |
|
| 53 | +| [FOXC1](FOXC1) | 1 | (Schmitz et al. 2018) | |
|
| 54 | +| [FOXO1](FOXO1) | 1 | (Morin et al. 2011; Schmitz et al. 2012) | |
|
| 55 | +| [GNA13](GNA13) | 1 | (Morin et al. 2011; Love et al. 2012) | |
|
| 56 | +| [GNAI2](GNAI2) | 1 | (Morin et al. 2013; Grande et al. 2019) | |
|
| 57 | +| [GRB2](GRB2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011; Panea et al. 2019) | |
|
| 58 | +| [GRHPR](GRHPR) | 1 | (Arthur et al. 2018) | |
|
| 59 | +| [HIST1H1B](HIST1H1B) | 1 | (Chapuy et al. 2018; Krysiak et al. 2017) | |
|
| 60 | +| [HIST1H1C](HIST1H1C) | 1 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 61 | +| [HIST1H1D](HIST1H1D) | 1 | (Morin et al. 2013; Krysiak et al. 2017) | |
|
| 62 | +| [HIST1H1E](HIST1H1E) | 1 | (Morin et al. 2013; Krysiak et al. 2017; Grande et al. 2019) | |
|
| 63 | +| [HIST1H2AC](HIST1H2AC) | 1 | (Morin et al. 2013; Krysiak et al. 2017) | |
|
| 64 | +| [HIST1H2AM](HIST1H2AM) | 1 | (Krysiak et al. 2017; Panea et al. 2019) | |
|
| 65 | +| [HIST1H2BC](HIST1H2BC) | 1 | (Reddy et al. 2017; Krysiak et al. 2017) | |
|
| 66 | +| [HIST1H2BK](HIST1H2BK) | 1 | (Panea et al. 2019) | |
|
| 67 | +| [HIST1H3B](HIST1H3B) | 1 | (Zhang et al. 2013) | |
|
| 68 | +| [HIST2H2BE](HIST2H2BE) | 1 | (Schmitz et al. 2018) | |
|
| 69 | +| [HLA-A](HLA-A) | 1 | \[@\] | |
|
| 70 | +| [HLA-B](HLA-B) | 1 | \[@\] | |
|
| 71 | +| [HLA-C](HLA-C) | 1 | | |
|
| 72 | +| [HLA-DMA](HLA-DMA) | 1 | | |
|
| 73 | +| [HLA-DMB](HLA-DMB) | 1 | \[@\] | |
|
| 74 | +| [HLA-DQA1](HLA-DQA1) | 1 | (Hübschmann et al. 2021) | |
|
| 75 | +| [HNRNPD](HNRNPD) | 1 | | |
|
| 76 | +| [HNRNPH1](HNRNPH1) | 1 | (Pararajalingam et al. 2020) | |
|
| 77 | +| [HNRNPU](HNRNPU) | 1 | (Reddy et al. 2017; Panea et al. 2019) | |
|
| 78 | +| [HVCN1](HVCN1) | 1 | (Krysiak et al. 2017) | |
|
| 79 | +| [IKZF3](IKZF3) | 1 | (Morin et al. 2013; Panea et al. 2019) | |
|
| 80 | +| [IL16](IL16) | 1 | | |
|
| 81 | +| [IL4R](IL4R) | 1 | (Duns et al. 2021) | |
|
| 82 | +| [IRF4](IRF4) | 1 | (Morin et al. 2011) | |
|
| 83 | +| [IRF8](IRF8) | 1 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 84 | +| [ITPKB](ITPKB) | 1 | (Schmitz et al. 2018) | |
|
| 85 | +| [JUNB](JUNB) | 1 | (Reddy et al. 2017) | |
|
| 86 | +| [KLF2](KLF2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 87 | +| [KLHL14](KLHL14) | 1 | (Zhang et al. 2013) | |
|
| 88 | +| [KLHL6](KLHL6) | 1 | \[Morin et al. (2011); @\] | |
|
| 89 | +| [KMT2C](KMT2C) | 1 | (Zhang et al. 2013; Zhou et al. 2019) | |
|
| 90 | +| [KMT2D](KMT2D) | 1 | (Morin et al. 2011; Grande et al. 2019) | |
|
| 91 | +| [KRAS](KRAS) | 1 | (Lohr et al. 2012) | |
|
| 92 | +| [LCOR](LCOR) | 1 | \[Arthur et al. (2018); @\] | |
|
| 93 | +| [LTB](LTB) | 1 | \[Chapuy et al. (2018); @\] | |
|
| 94 | +| [LYN](LYN) | 1 | (Chapuy et al. 2018) | |
|
| 95 | +| [MCL1](MCL1) | 1 | (Reddy et al. 2017; Panea et al. 2019) | |
|
| 96 | +| [MEF2B](MEF2B) | 1 | \[Morin et al. (2011); @\] | |
|
| 97 | +| [MEF2C](MEF2C) | 1 | (Arthur et al. 2018) | |
|
| 98 | +| [MGA](MGA) | 1 | (Zhang et al. 2013) | |
|
| 99 | +| [MPEG1](MPEG1) | 1 | (Morin et al. 2013) | |
|
| 100 | +| [MS4A1](MS4A1) | 1 | (Rushton et al. 2020) | |
|
| 101 | +| [MTOR](MTOR) | 1 | (Zhang et al. 2013; Panea et al. 2019) | |
|
| 102 | +| [MYC](MYC) | 1 | (L. Pasqualucci et al. 2001; Johnston and Carroll 1992) | |
|
| 103 | +| [MYD88](MYD88) | 1 | (Ngo et al. 2011) | |
|
| 104 | +| [MYOM2](MYOM2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 105 | +| [NCOR2](NCOR2) | 1 | (Schmitz et al. 2012) | |
|
| 106 | +| [NFKB1](NFKB1) | 1 | | |
|
| 107 | +| [NFKBIA](NFKBIA) | 1 | (Lake et al. 2009; Russler-Germain et al. 2023) | |
|
| 108 | +| [NFKBIE](NFKBIE) | 1 | (Morin et al. 2016) | |
|
| 109 | +| [NFKBIZ](NFKBIZ) | 1 | (Morin et al. 2016) | |
|
| 110 | +| [NLRC5](NLRC5) | 1 | | |
|
| 111 | +| [NOL9](NOL9) | 1 | (Schmitz et al. 2018) | |
|
| 112 | +| [NOTCH1](NOTCH1) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011; Love et al. 2012) | |
|
| 113 | +| [NOTCH2](NOTCH2) | 1 | (Trøen et al. 2008; Panea et al. 2019) | |
|
| 114 | +| [OSBPL10](OSBPL10) | 1 | (Arthur et al. 2018) | |
|
| 115 | +| [P2RY8](P2RY8) | 1 | (Lohr et al. 2012; Muppidi et al. 2014) | |
|
| 116 | +| [PCBP1](PCBP1) | 1 | (Schmitz et al. 2012) | |
|
| 117 | +| [PIM1](PIM1) | 1 | (L. Pasqualucci et al. 2001; Burkhardt et al. 2022) | |
|
| 118 | +| [PIM2](PIM2) | 1 | (Arthur et al. 2018) | |
|
| 119 | +| [POU2AF1](POU2AF1) | 1 | (Krysiak et al. 2017) | |
|
| 120 | +| [POU2F2](POU2F2) | 1 | (Zhang et al. 2013; Krysiak et al. 2017) | |
|
| 121 | +| [PRDM1](PRDM1) | 1 | \[(**pasqualucciInactivationPRDM1BLIMP12006?**); @\] | |
|
| 122 | +| [PRKDC](PRKDC) | 1 | (Schmitz et al. 2018; Hübschmann et al. 2021) | |
|
| 123 | +| [PTEN](PTEN) | 1 | (Love et al. 2012) | |
|
| 124 | +| [PTPRD](PTPRD) | 1 | | |
|
| 125 | +| [RB1](RB1) | 1 | (Morin et al. 2013) | |
|
| 126 | +| [RFX7](RFX7) | 1 | (Grande et al. 2019) | |
|
| 127 | +| [RFXAP](RFXAP) | 1 | | |
|
| 128 | +| [RHOA](RHOA) | 1 | (L. Pasqualucci et al. 2001; Richter et al. 2012) | |
|
| 129 | +| [RRAGC](RRAGC) | 1 | (Okosun et al. 2016) | |
|
| 130 | +| [S1PR2](S1PR2) | 1 | (Morin et al. 2011; Muppidi et al. 2014) | |
|
| 131 | +| [SETD1B](SETD1B) | 1 | (Reddy et al. 2017) | |
|
| 132 | +| [SF3B1](SF3B1) | 1 | (Love et al. 2012) | |
|
| 133 | +| [SGK1](SGK1) | 1 | (Morin et al. 2011) | |
|
| 134 | +| [SIN3A](SIN3A) | 1 | (Grande et al. 2019) | |
|
| 135 | +| [SMARCA4](SMARCA4) | 1 | (Zhang et al. 2013; Krysiak et al. 2017; Richter et al. 2012) | |
|
| 136 | +| [SOCS1](SOCS1) | 1 | (Morin et al. 2011) | |
|
| 137 | +| [SPEN](SPEN) | 1 | (Rossi et al. 2012) | |
|
| 138 | +| [STAT3](STAT3) | 1 | (Ohgami et al. 2014) | |
|
| 139 | +| [STAT6](STAT6) | 1 | (Yildiz et al. 2015) | |
|
| 140 | +| [TAF1](TAF1) | 1 | (Morin et al. 2013) | |
|
| 141 | +| [TBL1XR1](TBL1XR1) | 1 | (Mareschal et al. 2016) | |
|
| 142 | +| [TET2](TET2) | 1 | (Albuquerque et al. 2017; Panea et al. 2019) | |
|
| 143 | +| [TMEM30A](TMEM30A) | 1 | (Morin et al. 2011) | |
|
| 144 | +| [TMSB4X](TMSB4X) | 1 | (Albuquerque et al. 2017) | |
|
| 145 | +| [TNFAIP3](TNFAIP3) | 1 | (Compagno et al. 2009) | |
|
| 146 | +| [TNFRSF14](TNFRSF14) | 1 | (Cheung et al. 2010) | |
|
| 147 | +| [TOX](TOX) | 1 | (Reddy et al. 2017) | |
|
| 148 | +| [TP53](TP53) | 1 | (Morin et al. 2011; Wilda et al. 2004) | |
|
| 149 | +| [TRIP12](TRIP12) | 1 | | |
|
| 150 | +| [TRRAP](TRRAP) | 1 | (Parry et al. 2013) | |
|
| 151 | +| [UBE2A](UBE2A) | 1 | (Reddy et al. 2017) | |
|
| 152 | +| [UNC5C](UNC5C) | 1 | | |
|
| 153 | +| [USP7](USP7) | 1 | (Grande et al. 2019) | |
|
| 154 | +| [VPS13B](VPS13B) | 1 | | |
|
| 155 | +| [WEE1](WEE1) | 1 | (Schmitz et al. 2018) | |
|
| 156 | +| [XPO1](XPO1) | 1 | (Mareschal et al. 2016) | |
|
| 157 | +| [ZC3H12A](ZC3H12A) | 1 | (Arthur et al. 2018) | |
|
| 158 | +| [ZFP36L1](ZFP36L1) | 1 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 159 | +| [ZNF292](ZNF292) | 1 | (Zhang et al. 2013) | |
|
| 160 | +| [ZNF608](ZNF608) | 1 | (Zhang et al. 2013; Krysiak et al. 2017) | |
|
| 159 | 161 | |
| 160 | 162 | ## Tier 2 DLBCL genes |
| 161 | 163 | |
| 162 | -| Gene | Tier | Relevant references | |
|
| 163 | -|:----------------------:|:----:|:------------------------------------------------:| |
|
| 164 | -| [ABI3BP](ABI3BP) | 2 | (Morin et al. 2013) | |
|
| 165 | -| [ADAMTS1](ADAMTS1) | 2 | (Hübschmann et al. 2021) | |
|
| 166 | -| [AICDA](AICDA) | 2 | (Arthur et al. 2018) | |
|
| 167 | -| [ANKRD12](ANKRD12) | 2 | (Hübschmann et al. 2021) | |
|
| 168 | -| [ANKRD17](ANKRD17) | 2 | (Reddy et al. 2017) | |
|
| 169 | -| [ARID1B](ARID1B) | 2 | (Reddy et al. 2017) | |
|
| 170 | -| [ARID5B](ARID5B) | 2 | (Reddy et al. 2017) | |
|
| 171 | -| [ATR](ATR) | 2 | (Reddy et al. 2017) | |
|
| 172 | -| [BIRC3](BIRC3) | 2 | (Arthur et al. 2018) | |
|
| 173 | -| [BLK](BLK) | 2 | | |
|
| 174 | -| [BRINP3](BRINP3) | 2 | (Reddy et al. 2017) | |
|
| 175 | -| [BTBD3](BTBD3) | 2 | (Reddy et al. 2017) | |
|
| 176 | -| [CADPS2](CADPS2) | 2 | (Hübschmann et al. 2021) | |
|
| 177 | -| [CBLB](CBLB) | 2 | (Reddy et al. 2017) | |
|
| 178 | -| [CCL4](CCL4) | 2 | (Chapuy et al. 2018) | |
|
| 179 | -| [CD22](CD22) | 2 | (Reddy et al. 2017) | |
|
| 180 | -| [CD44](CD44) | 2 | (Arthur et al. 2018) | |
|
| 181 | -| [CD74](CD74) | 2 | (Arthur et al. 2018) | |
|
| 182 | -| [CDC73](CDC73) | 2 | (Reddy et al. 2017) | |
|
| 183 | -| [CDH9](CDH9) | 2 | (Morin et al. 2013) | |
|
| 184 | -| [CHD1](CHD1) | 2 | (Reddy et al. 2017) | |
|
| 185 | -| [CHD8](CHD8) | 2 | (Reddy et al. 2017) | |
|
| 186 | -| [CHST2](CHST2) | 2 | (Reddy et al. 2017) | |
|
| 187 | -| [CNOT2](CNOT2) | 2 | (Hübschmann et al. 2021) | |
|
| 188 | -| [CNTNAP5](CNTNAP5) | 2 | (Morin et al. 2013) | |
|
| 189 | -| [COQ7](COQ7) | 2 | (Chapuy et al. 2018) | |
|
| 190 | -| [CRIP1](CRIP1) | 2 | (Chapuy et al. 2018) | |
|
| 191 | -| [DCAF6](DCAF6) | 2 | (Reddy et al. 2017) | |
|
| 192 | -| [DDX10](DDX10) | 2 | (Reddy et al. 2017) | |
|
| 193 | -| [DHX16](DHX16) | 2 | (Hübschmann et al. 2021) | |
|
| 194 | -| [DICER1](DICER1) | 2 | (Reddy et al. 2017) | |
|
| 195 | -| [DNAH5](DNAH5) | 2 | (Morin et al. 2013) | |
|
| 196 | -| [DNM2](DNM2) | 2 | (Hübschmann et al. 2021) | |
|
| 197 | -| [DNMT3A](DNMT3A) | 2 | (Reddy et al. 2017) | |
|
| 198 | -| [DOCK1](DOCK1) | 2 | (Chapuy et al. 2018) | |
|
| 199 | -| [DSG4](DSG4) | 2 | (Morin et al. 2013) | |
|
| 200 | -| [EIF2AK3](EIF2AK3) | 2 | | |
|
| 201 | -| [EZR](EZR) | 2 | | |
|
| 202 | -| [FAM102A](FAM102A) | 2 | | |
|
| 203 | -| [FAM38B](FAM38B) | 2 | (Morin et al. 2013) | |
|
| 204 | -| [FANK1](FANK1) | 2 | | |
|
| 205 | -| [FAT4](FAT4) | 2 | (Morin et al. 2013) | |
|
| 206 | -| [FCRL3](FCRL3) | 2 | | |
|
| 207 | -| [FNBP1](FNBP1) | 2 | | |
|
| 208 | -| [FNDC1](FNDC1) | 2 | (Morin et al. 2013) | |
|
| 209 | -| [FOXP1](FOXP1) | 2 | (Reddy et al. 2017) | |
|
| 210 | -| [FUBP1](FUBP1) | 2 | (Reddy et al. 2017) | |
|
| 211 | -| [FUT5](FUT5) | 2 | (Chapuy et al. 2018) | |
|
| 212 | -| [GABRA2](GABRA2) | 2 | (Chapuy et al. 2018) | |
|
| 213 | -| [GAK](GAK) | 2 | (Hübschmann et al. 2021) | |
|
| 214 | -| [GNAS](GNAS) | 2 | (Reddy et al. 2017) | |
|
| 215 | -| [GOLGA5](GOLGA5) | 2 | (Reddy et al. 2017) | |
|
| 216 | -| [GPC5](GPC5) | 2 | (Schmitz et al. 2018) | |
|
| 217 | -| [GSG2](GSG2) | 2 | (Schmitz et al. 2018) | |
|
| 218 | -| [HDAC7](HDAC7) | 2 | (Morin et al. 2013) | |
|
| 219 | -| [HIST1H2AG](HIST1H2AG) | 2 | (Morin et al. 2013; Krysiak et al. 2017) | |
|
| 220 | -| [HNF1B](HNF1B) | 2 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 221 | -| [HRAS](HRAS) | 2 | (Reddy et al. 2017) | |
|
| 222 | -| [ID3](ID3) | 2 | (Schmitz et al. 2012) | |
|
| 223 | -| [IER2](IER2) | 2 | (Morin et al. 2013) | |
|
| 224 | -| [IFNGR1](IFNGR1) | 2 | (Morin et al. 2013) | |
|
| 225 | -| [IGLL5](IGLL5) | 2 | (Russler-Germain et al. 2023) | |
|
| 226 | -| [IKBKB](IKBKB) | 2 | (Reddy et al. 2017) | |
|
| 227 | -| [IKBKE](IKBKE) | 2 | (Hübschmann et al. 2021) | |
|
| 228 | -| [IL6](IL6) | 2 | (Chapuy et al. 2018) | |
|
| 229 | -| [INO80](INO80) | 2 | (Zhang et al. 2013) | |
|
| 230 | -| [IRAG2](IRAG2) | 2 | | |
|
| 231 | -| [IRF1](IRF1) | 2 | (Hübschmann et al. 2021) | |
|
| 232 | -| [JAK1](JAK1) | 2 | (Zhang et al. 2013) | |
|
| 233 | -| [JAK3](JAK3) | 2 | (Zhang et al. 2013) | |
|
| 234 | -| [KCMF1](KCMF1) | 2 | (Reddy et al. 2017) | |
|
| 235 | -| [KLHL21](KLHL21) | 2 | (Schmitz et al. 2018) | |
|
| 236 | -| [LAMA5](LAMA5) | 2 | (Schmitz et al. 2018) | |
|
| 237 | -| [LAPTM5](LAPTM5) | 2 | (Hübschmann et al. 2021) | |
|
| 238 | -| [LIN54](LIN54) | 2 | (Reddy et al. 2017) | |
|
| 239 | -| [LPP](LPP) | 2 | (Arthur et al. 2018) | |
|
| 240 | -| [LRP12](LRP12) | 2 | (Hübschmann et al. 2021) | |
|
| 241 | -| [LRRN3](LRRN3) | 2 | (Morin et al. 2013) | |
|
| 242 | -| [MAGT1](MAGT1) | 2 | (Reddy et al. 2017) | |
|
| 243 | -| [MALAT1](MALAT1) | 2 | (Arthur et al. 2018) | |
|
| 244 | -| [MAP2K1](MAP2K1) | 2 | (Shin et al. 2015; Louissaint et al. 2016) | |
|
| 245 | -| [MAP4K4](MAP4K4) | 2 | (Reddy et al. 2017) | |
|
| 246 | -| [MARK1](MARK1) | 2 | (Reddy et al. 2017) | |
|
| 247 | -| [MECOM](MECOM) | 2 | (Reddy et al. 2017) | |
|
| 248 | -| [MET](MET) | 2 | (Reddy et al. 2017) | |
|
| 249 | -| [MIR142](MIR142) | 2 | (Kwanhian et al. 2012) | |
|
| 250 | -| [MIR155HG](MIR155HG) | 2 | | |
|
| 251 | -| [MPDZ](MPDZ) | 2 | (Morin et al. 2013) | |
|
| 252 | -| [MSH2](MSH2) | 2 | (Reddy et al. 2017) | |
|
| 253 | -| [MSH6](MSH6) | 2 | (Reddy et al. 2017) | |
|
| 254 | -| [MYB](MYB) | 2 | (Reddy et al. 2017) | |
|
| 255 | -| [MYBPC2](MYBPC2) | 2 | (Schmitz et al. 2018) | |
|
| 256 | -| [MYO1E](MYO1E) | 2 | | |
|
| 257 | -| [N2RF2](N2RF2) | 2 | (Hübschmann et al. 2021) | |
|
| 258 | -| [NANOG](NANOG) | 2 | (Chapuy et al. 2018) | |
|
| 259 | -| [NAV1](NAV1) | 2 | (Chapuy et al. 2018) | |
|
| 260 | -| [NCOA3](NCOA3) | 2 | | |
|
| 261 | -| [NCOR1](NCOR1) | 2 | (Reddy et al. 2017) | |
|
| 262 | -| [NEAT1](NEAT1) | 2 | (Arthur et al. 2018) | |
|
| 263 | -| [NF1](NF1) | 2 | (Reddy et al. 2017) | |
|
| 264 | -| [NFKB2](NFKB2) | 2 | (Reddy et al. 2017) | |
|
| 265 | -| [NLRP5](NLRP5) | 2 | (Morin et al. 2013) | |
|
| 266 | -| [NLRP8](NLRP8) | 2 | (Chapuy et al. 2018) | |
|
| 267 | -| [ODZ3](ODZ3) | 2 | (Morin et al. 2013) | |
|
| 268 | -| [P2RX5](P2RX5) | 2 | (Morin et al. 2013) | |
|
| 269 | -| [PAPOLG](PAPOLG) | 2 | (Schmitz et al. 2018) | |
|
| 270 | -| [PASK](PASK) | 2 | (Morin et al. 2013) | |
|
| 271 | -| [PAX5](PAX5) | 2 | (L. Pasqualucci et al. 2001) | |
|
| 272 | -| [PCDHB11](PCDHB11) | 2 | (Morin et al. 2013) | |
|
| 273 | -| [PCLO](PCLO) | 2 | (Lohr et al. 2012) | |
|
| 274 | -| [PDE4DIP](PDE4DIP) | 2 | (Chapuy et al. 2018) | |
|
| 275 | -| [PDS5B](PDS5B) | 2 | (Morin et al. 2013; Hübschmann et al. 2021) | |
|
| 276 | -| [PHF6](PHF6) | 2 | (Reddy et al. 2017) | |
|
| 277 | -| [PIK3CD](PIK3CD) | 2 | (Reddy et al. 2017) | |
|
| 278 | -| [PIK3R1](PIK3R1) | 2 | (Zhang et al. 2013) | |
|
| 279 | -| [PKD1](PKD1) | 2 | (Morin et al. 2013) | |
|
| 280 | -| [PNPO](PNPO) | 2 | (Hübschmann et al. 2021) | |
|
| 281 | -| [POGZ](POGZ) | 2 | (Morin et al. 2013) | |
|
| 282 | -| [PPP1R9B](PPP1R9B) | 2 | | |
|
| 283 | -| [PRKCB](PRKCB) | 2 | (Morin et al. 2013) | |
|
| 284 | -| [PRPS1](PRPS1) | 2 | (Chapuy et al. 2018) | |
|
| 285 | -| [PTMA](PTMA) | 2 | | |
|
| 286 | -| [PTPN1](PTPN1) | 2 | | |
|
| 287 | -| [PTPN23](PTPN23) | 2 | (Morin et al. 2013) | |
|
| 288 | -| [PTPN6](PTPN6) | 2 | (Reddy et al. 2017) | |
|
| 289 | -| [PTPRK](PTPRK) | 2 | (Reddy et al. 2017) | |
|
| 290 | -| [RAC2](RAC2) | 2 | (Hübschmann et al. 2021) | |
|
| 291 | -| [RAD9A](RAD9A) | 2 | (Chapuy et al. 2018) | |
|
| 292 | -| [RARA](RARA) | 2 | (Reddy et al. 2017) | |
|
| 293 | -| [RCC](RCC) | 2 | | |
|
| 294 | -| [RFTN1](RFTN1) | 2 | (Arthur et al. 2018) | |
|
| 295 | -| [RHEX](RHEX) | 2 | | |
|
| 296 | -| [RHOH](RHOH) | 2 | | |
|
| 297 | -| [RUBCNL](RUBCNL) | 2 | | |
|
| 298 | -| [RUNX1](RUNX1) | 2 | (Reddy et al. 2017) | |
|
| 299 | -| [SAMD9L](SAMD9L) | 2 | (Morin et al. 2013) | |
|
| 300 | -| [SARM1](SARM1) | 2 | (Morin et al. 2013) | |
|
| 301 | -| [SEL1L3](SEL1L3) | 2 | | |
|
| 302 | -| [SEPTIN9](SEPTIN9) | 2 | | |
|
| 303 | -| [SERPINA9](SERPINA9) | 2 | (Arthur et al. 2018) | |
|
| 304 | -| [SETD2](SETD2) | 2 | (Zhang et al. 2013) | |
|
| 305 | -| [SETD5](SETD5) | 2 | (Reddy et al. 2017) | |
|
| 306 | -| [SIAH2](SIAH2) | 2 | (Hübschmann et al. 2021) | |
|
| 307 | -| [SLC34A2](SLC34A2) | 2 | (Hübschmann et al. 2021) | |
|
| 308 | -| [SMEK1](SMEK1) | 2 | (Chapuy et al. 2018) | |
|
| 309 | -| [SRRM2](SRRM2) | 2 | (Morin et al. 2013; Russler-Germain et al. 2023) | |
|
| 310 | -| [ST6GAL1](ST6GAL1) | 2 | (Arthur et al. 2018) | |
|
| 311 | -| [STAT5B](STAT5B) | 2 | (Zhang et al. 2013) | |
|
| 312 | -| [SYK](SYK) | 2 | (Reddy et al. 2017) | |
|
| 313 | -| [SYPL1](SYPL1) | 2 | (Morin et al. 2013) | |
|
| 314 | -| [TAP1](TAP1) | 2 | (Schmitz et al. 2018) | |
|
| 315 | -| [TBC1D4](TBC1D4) | 2 | (Arthur et al. 2018) | |
|
| 316 | -| [TCL1A](TCL1A) | 2 | | |
|
| 317 | -| [TGFBR2](TGFBR2) | 2 | (Reddy et al. 2017) | |
|
| 318 | -| [TIPARP](TIPARP) | 2 | (Reddy et al. 2017) | |
|
| 319 | -| [TLR2](TLR2) | 2 | (Chapuy et al. 2018) | |
|
| 320 | -| [TRAF3](TRAF3) | 2 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 321 | -| [TRAF6](TRAF6) | 2 | (Hübschmann et al. 2021) | |
|
| 322 | -| [UBE2J1](UBE2J1) | 2 | | |
|
| 323 | -| [UBR5](UBR5) | 2 | (Zhang et al. 2013) | |
|
| 324 | -| [UNC5B](UNC5B) | 2 | (Hübschmann et al. 2021) | |
|
| 325 | -| [UNC5D](UNC5D) | 2 | | |
|
| 326 | -| [WAC](WAC) | 2 | (Reddy et al. 2017) | |
|
| 327 | -| [WDFY3](WDFY3) | 2 | (Morin et al. 2013) | |
|
| 328 | -| [WNK1](WNK1) | 2 | (Hübschmann et al. 2021) | |
|
| 329 | -| [XBP1](XBP1) | 2 | | |
|
| 330 | -| [YY1](YY1) | 2 | (Reddy et al. 2017) | |
|
| 331 | -| [ZBTB7A](ZBTB7A) | 2 | (Reddy et al. 2017) | |
|
| 332 | -| [ZCCHC7](ZCCHC7) | 2 | (Arthur et al. 2018) | |
|
| 333 | -| [ZEB2](ZEB2) | 2 | (Zhang et al. 2013) | |
|
| 334 | -| [ZFAT](ZFAT) | 2 | (Reddy et al. 2017) | |
|
| 335 | -| [ZFX](ZFX) | 2 | (Reddy et al. 2017) | |
|
| 336 | -| [ZNF217](ZNF217) | 2 | (Hübschmann et al. 2021) | |
|
| 337 | -| [ZNF423](ZNF423) | 2 | (Chapuy et al. 2018) | |
|
| 164 | +| Gene | Tier | Relevant references | |
|
| 165 | +|:----------------------:|:----:|:-----------------------------------------------------------:| |
|
| 166 | +| [ABI3BP](ABI3BP) | 2 | (Morin et al. 2013) | |
|
| 167 | +| [ADAMTS1](ADAMTS1) | 2 | (Hübschmann et al. 2021) | |
|
| 168 | +| [AICDA](AICDA) | 2 | (Arthur et al. 2018) | |
|
| 169 | +| [ANKRD12](ANKRD12) | 2 | (Hübschmann et al. 2021) | |
|
| 170 | +| [ANKRD17](ANKRD17) | 2 | (Reddy et al. 2017) | |
|
| 171 | +| [ARID1B](ARID1B) | 2 | (Reddy et al. 2017) | |
|
| 172 | +| [ARID5B](ARID5B) | 2 | (Reddy et al. 2017) | |
|
| 173 | +| [ATR](ATR) | 2 | (Reddy et al. 2017) | |
|
| 174 | +| [BIRC3](BIRC3) | 2 | (Arthur et al. 2018) | |
|
| 175 | +| [BLK](BLK) | 2 | | |
|
| 176 | +| [BRINP3](BRINP3) | 2 | (Reddy et al. 2017) | |
|
| 177 | +| [BTBD3](BTBD3) | 2 | (Reddy et al. 2017) | |
|
| 178 | +| [CADPS2](CADPS2) | 2 | (Hübschmann et al. 2021) | |
|
| 179 | +| [CBLB](CBLB) | 2 | (Reddy et al. 2017) | |
|
| 180 | +| [CCL4](CCL4) | 2 | (Chapuy et al. 2018) | |
|
| 181 | +| [CD22](CD22) | 2 | (Reddy et al. 2017) | |
|
| 182 | +| [CD44](CD44) | 2 | (Arthur et al. 2018) | |
|
| 183 | +| [CD74](CD74) | 2 | (Arthur et al. 2018) | |
|
| 184 | +| [CDC73](CDC73) | 2 | (Reddy et al. 2017; Love et al. 2012) | |
|
| 185 | +| [CDH9](CDH9) | 2 | (Morin et al. 2013) | |
|
| 186 | +| [CHD1](CHD1) | 2 | (Reddy et al. 2017) | |
|
| 187 | +| [CHD8](CHD8) | 2 | (Reddy et al. 2017; Grande et al. 2019) | |
|
| 188 | +| [CHST2](CHST2) | 2 | (Reddy et al. 2017) | |
|
| 189 | +| [CNOT2](CNOT2) | 2 | (Hübschmann et al. 2021) | |
|
| 190 | +| [CNTNAP5](CNTNAP5) | 2 | (Morin et al. 2013) | |
|
| 191 | +| [COQ7](COQ7) | 2 | (Chapuy et al. 2018) | |
|
| 192 | +| [CRIP1](CRIP1) | 2 | (Chapuy et al. 2018) | |
|
| 193 | +| [DCAF6](DCAF6) | 2 | (Reddy et al. 2017) | |
|
| 194 | +| [DDX10](DDX10) | 2 | (Reddy et al. 2017) | |
|
| 195 | +| [DHX16](DHX16) | 2 | (Hübschmann et al. 2021) | |
|
| 196 | +| [DICER1](DICER1) | 2 | (Reddy et al. 2017) | |
|
| 197 | +| [DNAH5](DNAH5) | 2 | (Morin et al. 2013) | |
|
| 198 | +| [DNM2](DNM2) | 2 | (Hübschmann et al. 2021) | |
|
| 199 | +| [DNMT3A](DNMT3A) | 2 | (Reddy et al. 2017) | |
|
| 200 | +| [DOCK1](DOCK1) | 2 | (Chapuy et al. 2018) | |
|
| 201 | +| [DSG4](DSG4) | 2 | (Morin et al. 2013) | |
|
| 202 | +| [EIF2AK3](EIF2AK3) | 2 | | |
|
| 203 | +| [EZR](EZR) | 2 | | |
|
| 204 | +| [FAM102A](FAM102A) | 2 | | |
|
| 205 | +| [FAM38B](FAM38B) | 2 | (Morin et al. 2013) | |
|
| 206 | +| [FANK1](FANK1) | 2 | | |
|
| 207 | +| [FAT4](FAT4) | 2 | (Morin et al. 2013) | |
|
| 208 | +| [FCRL3](FCRL3) | 2 | | |
|
| 209 | +| [FNBP1](FNBP1) | 2 | | |
|
| 210 | +| [FNDC1](FNDC1) | 2 | (Morin et al. 2013) | |
|
| 211 | +| [FOXP1](FOXP1) | 2 | (Reddy et al. 2017) | |
|
| 212 | +| [FUBP1](FUBP1) | 2 | (Reddy et al. 2017) | |
|
| 213 | +| [FUT5](FUT5) | 2 | (Chapuy et al. 2018) | |
|
| 214 | +| [GABRA2](GABRA2) | 2 | (Chapuy et al. 2018) | |
|
| 215 | +| [GAK](GAK) | 2 | (Hübschmann et al. 2021) | |
|
| 216 | +| [GNAS](GNAS) | 2 | (Reddy et al. 2017) | |
|
| 217 | +| [GOLGA5](GOLGA5) | 2 | (Reddy et al. 2017) | |
|
| 218 | +| [GPC5](GPC5) | 2 | (Schmitz et al. 2018) | |
|
| 219 | +| [GSG2](GSG2) | 2 | (Schmitz et al. 2018) | |
|
| 220 | +| [HDAC7](HDAC7) | 2 | (Morin et al. 2013) | |
|
| 221 | +| [HIST1H2AG](HIST1H2AG) | 2 | (Morin et al. 2013; Krysiak et al. 2017; Panea et al. 2019) | |
|
| 222 | +| [HNF1B](HNF1B) | 2 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 223 | +| [HRAS](HRAS) | 2 | (Reddy et al. 2017) | |
|
| 224 | +| [ID3](ID3) | 2 | (Schmitz et al. 2012; Richter et al. 2012) | |
|
| 225 | +| [IER2](IER2) | 2 | (Morin et al. 2013) | |
|
| 226 | +| [IFNGR1](IFNGR1) | 2 | (Morin et al. 2013) | |
|
| 227 | +| [IGLL5](IGLL5) | 2 | (Russler-Germain et al. 2023; Panea et al. 2019) | |
|
| 228 | +| [IKBKB](IKBKB) | 2 | (Reddy et al. 2017) | |
|
| 229 | +| [IKBKE](IKBKE) | 2 | (Hübschmann et al. 2021) | |
|
| 230 | +| [IL6](IL6) | 2 | (Chapuy et al. 2018) | |
|
| 231 | +| [INO80](INO80) | 2 | (Zhang et al. 2013) | |
|
| 232 | +| [IRAG2](IRAG2) | 2 | | |
|
| 233 | +| [IRF1](IRF1) | 2 | (Hübschmann et al. 2021) | |
|
| 234 | +| [JAK1](JAK1) | 2 | (Zhang et al. 2013) | |
|
| 235 | +| [JAK3](JAK3) | 2 | (Zhang et al. 2013) | |
|
| 236 | +| [KCMF1](KCMF1) | 2 | (Reddy et al. 2017) | |
|
| 237 | +| [KLHL21](KLHL21) | 2 | (Schmitz et al. 2018) | |
|
| 238 | +| [LAMA5](LAMA5) | 2 | (Schmitz et al. 2018) | |
|
| 239 | +| [LAPTM5](LAPTM5) | 2 | (Hübschmann et al. 2021) | |
|
| 240 | +| [LIN54](LIN54) | 2 | (Reddy et al. 2017) | |
|
| 241 | +| [LPP](LPP) | 2 | (Arthur et al. 2018) | |
|
| 242 | +| [LRP12](LRP12) | 2 | (Hübschmann et al. 2021) | |
|
| 243 | +| [LRRN3](LRRN3) | 2 | (Morin et al. 2013) | |
|
| 244 | +| [MAGT1](MAGT1) | 2 | (Reddy et al. 2017) | |
|
| 245 | +| [MALAT1](MALAT1) | 2 | (Arthur et al. 2018) | |
|
| 246 | +| [MAP2K1](MAP2K1) | 2 | (Shin et al. 2015; Louissaint et al. 2016) | |
|
| 247 | +| [MAP4K4](MAP4K4) | 2 | (Reddy et al. 2017) | |
|
| 248 | +| [MARK1](MARK1) | 2 | (Reddy et al. 2017) | |
|
| 249 | +| [MECOM](MECOM) | 2 | (Reddy et al. 2017) | |
|
| 250 | +| [MET](MET) | 2 | (Reddy et al. 2017) | |
|
| 251 | +| [MIR142](MIR142) | 2 | (Kwanhian et al. 2012; Grande et al. 2019) | |
|
| 252 | +| [MIR155HG](MIR155HG) | 2 | | |
|
| 253 | +| [MPDZ](MPDZ) | 2 | (Morin et al. 2013) | |
|
| 254 | +| [MSH2](MSH2) | 2 | (Reddy et al. 2017) | |
|
| 255 | +| [MSH6](MSH6) | 2 | (Reddy et al. 2017) | |
|
| 256 | +| [MYB](MYB) | 2 | (Reddy et al. 2017) | |
|
| 257 | +| [MYBPC2](MYBPC2) | 2 | (Schmitz et al. 2018) | |
|
| 258 | +| [MYO1E](MYO1E) | 2 | | |
|
| 259 | +| [N2RF2](N2RF2) | 2 | (Hübschmann et al. 2021) | |
|
| 260 | +| [NANOG](NANOG) | 2 | (Chapuy et al. 2018) | |
|
| 261 | +| [NAV1](NAV1) | 2 | (Chapuy et al. 2018) | |
|
| 262 | +| [NCOA3](NCOA3) | 2 | | |
|
| 263 | +| [NCOR1](NCOR1) | 2 | (Reddy et al. 2017) | |
|
| 264 | +| [NEAT1](NEAT1) | 2 | (Arthur et al. 2018) | |
|
| 265 | +| [NF1](NF1) | 2 | (Reddy et al. 2017) | |
|
| 266 | +| [NFKB2](NFKB2) | 2 | (Reddy et al. 2017) | |
|
| 267 | +| [NLRP5](NLRP5) | 2 | (Morin et al. 2013) | |
|
| 268 | +| [NLRP8](NLRP8) | 2 | (Chapuy et al. 2018) | |
|
| 269 | +| [ODZ3](ODZ3) | 2 | (Morin et al. 2013) | |
|
| 270 | +| [P2RX5](P2RX5) | 2 | (Morin et al. 2013) | |
|
| 271 | +| [PAPOLG](PAPOLG) | 2 | (Schmitz et al. 2018) | |
|
| 272 | +| [PASK](PASK) | 2 | (Morin et al. 2013) | |
|
| 273 | +| [PAX5](PAX5) | 2 | (L. Pasqualucci et al. 2001) | |
|
| 274 | +| [PCDHB11](PCDHB11) | 2 | (Morin et al. 2013) | |
|
| 275 | +| [PCLO](PCLO) | 2 | (Lohr et al. 2012) | |
|
| 276 | +| [PDE4DIP](PDE4DIP) | 2 | (Chapuy et al. 2018) | |
|
| 277 | +| [PDS5B](PDS5B) | 2 | (Morin et al. 2013; Hübschmann et al. 2021) | |
|
| 278 | +| [PHF6](PHF6) | 2 | (Reddy et al. 2017; Thomas et al. 2023) | |
|
| 279 | +| [PIK3CD](PIK3CD) | 2 | (Reddy et al. 2017) | |
|
| 280 | +| [PIK3R1](PIK3R1) | 2 | (Zhang et al. 2013; Panea et al. 2019) | |
|
| 281 | +| [PKD1](PKD1) | 2 | (Morin et al. 2013) | |
|
| 282 | +| [PNPO](PNPO) | 2 | (Hübschmann et al. 2021) | |
|
| 283 | +| [POGZ](POGZ) | 2 | (Morin et al. 2013) | |
|
| 284 | +| [PPP1R9B](PPP1R9B) | 2 | | |
|
| 285 | +| [PRKCB](PRKCB) | 2 | (Morin et al. 2013) | |
|
| 286 | +| [PRPS1](PRPS1) | 2 | (Chapuy et al. 2018) | |
|
| 287 | +| [PTMA](PTMA) | 2 | | |
|
| 288 | +| [PTPN1](PTPN1) | 2 | | |
|
| 289 | +| [PTPN23](PTPN23) | 2 | (Morin et al. 2013) | |
|
| 290 | +| [PTPN6](PTPN6) | 2 | (Reddy et al. 2017) | |
|
| 291 | +| [PTPRK](PTPRK) | 2 | (Reddy et al. 2017) | |
|
| 292 | +| [RAC2](RAC2) | 2 | (Hübschmann et al. 2021; Panea et al. 2019) | |
|
| 293 | +| [RAD9A](RAD9A) | 2 | (Chapuy et al. 2018) | |
|
| 294 | +| [RARA](RARA) | 2 | (Reddy et al. 2017) | |
|
| 295 | +| [RCC](RCC) | 2 | | |
|
| 296 | +| [RFTN1](RFTN1) | 2 | (Arthur et al. 2018) | |
|
| 297 | +| [RHEX](RHEX) | 2 | | |
|
| 298 | +| [RHOH](RHOH) | 2 | | |
|
| 299 | +| [RUBCNL](RUBCNL) | 2 | | |
|
| 300 | +| [RUNX1](RUNX1) | 2 | (Reddy et al. 2017) | |
|
| 301 | +| [SAMD9L](SAMD9L) | 2 | (Morin et al. 2013) | |
|
| 302 | +| [SARM1](SARM1) | 2 | (Morin et al. 2013) | |
|
| 303 | +| [SEL1L3](SEL1L3) | 2 | | |
|
| 304 | +| [SEPTIN9](SEPTIN9) | 2 | | |
|
| 305 | +| [SERPINA9](SERPINA9) | 2 | (Arthur et al. 2018) | |
|
| 306 | +| [SETD2](SETD2) | 2 | (Zhang et al. 2013) | |
|
| 307 | +| [SETD5](SETD5) | 2 | (Reddy et al. 2017) | |
|
| 308 | +| [SIAH2](SIAH2) | 2 | (Hübschmann et al. 2021) | |
|
| 309 | +| [SLC34A2](SLC34A2) | 2 | (Hübschmann et al. 2021) | |
|
| 310 | +| [SMEK1](SMEK1) | 2 | (Chapuy et al. 2018) | |
|
| 311 | +| [SRRM2](SRRM2) | 2 | (Morin et al. 2013; Russler-Germain et al. 2023) | |
|
| 312 | +| [ST6GAL1](ST6GAL1) | 2 | (Arthur et al. 2018) | |
|
| 313 | +| [STAT5B](STAT5B) | 2 | (Zhang et al. 2013) | |
|
| 314 | +| [SYK](SYK) | 2 | (Reddy et al. 2017) | |
|
| 315 | +| [SYPL1](SYPL1) | 2 | (Morin et al. 2013) | |
|
| 316 | +| [TAP1](TAP1) | 2 | (Schmitz et al. 2018) | |
|
| 317 | +| [TBC1D4](TBC1D4) | 2 | (Arthur et al. 2018) | |
|
| 318 | +| [TCL1A](TCL1A) | 2 | (Grande et al. 2019) | |
|
| 319 | +| [TGFBR2](TGFBR2) | 2 | (Reddy et al. 2017) | |
|
| 320 | +| [TIPARP](TIPARP) | 2 | (Reddy et al. 2017) | |
|
| 321 | +| [TLR2](TLR2) | 2 | (Chapuy et al. 2018) | |
|
| 322 | +| [TRAF3](TRAF3) | 2 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 323 | +| [TRAF6](TRAF6) | 2 | (Hübschmann et al. 2021) | |
|
| 324 | +| [UBE2J1](UBE2J1) | 2 | | |
|
| 325 | +| [UBR5](UBR5) | 2 | (Zhang et al. 2013) | |
|
| 326 | +| [UNC5B](UNC5B) | 2 | (Hübschmann et al. 2021) | |
|
| 327 | +| [UNC5D](UNC5D) | 2 | | |
|
| 328 | +| [WAC](WAC) | 2 | (Reddy et al. 2017) | |
|
| 329 | +| [WDFY3](WDFY3) | 2 | (Morin et al. 2013) | |
|
| 330 | +| [WNK1](WNK1) | 2 | (Hübschmann et al. 2021; Thomas et al. 2023) | |
|
| 331 | +| [XBP1](XBP1) | 2 | | |
|
| 332 | +| [YY1](YY1) | 2 | (Reddy et al. 2017) | |
|
| 333 | +| [ZBTB7A](ZBTB7A) | 2 | (Reddy et al. 2017; Burkhardt et al. 2022) | |
|
| 334 | +| [ZCCHC7](ZCCHC7) | 2 | (Arthur et al. 2018) | |
|
| 335 | +| [ZEB2](ZEB2) | 2 | (Zhang et al. 2013) | |
|
| 336 | +| [ZFAT](ZFAT) | 2 | (Reddy et al. 2017) | |
|
| 337 | +| [ZFX](ZFX) | 2 | (Reddy et al. 2017) | |
|
| 338 | +| [ZNF217](ZNF217) | 2 | (Hübschmann et al. 2021) | |
|
| 339 | +| [ZNF423](ZNF423) | 2 | (Chapuy et al. 2018) | |
|
| 338 | 340 | |
| 339 | 341 | # References |
| 340 | 342 | |
| ... | ... | @@ -370,6 +372,17 @@ Lymphoma.” *Leukemia* 27 (3): 671–79. |
| 370 | 372 | |
| 371 | 373 | </div> |
| 372 | 374 | |
| 375 | +<div id="ref-burkhardtClinicalRelevanceMolecular2022b" |
|
| 376 | +class="csl-entry"> |
|
| 377 | + |
|
| 378 | +Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp |
|
| 379 | +Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance |
|
| 380 | +of Molecular Characteristics in Burkitt Lymphoma Differs According to |
|
| 381 | +Age.” *Nature Communications* 13 (1): 3881. |
|
| 382 | +<https://doi.org/10.1038/s41467-022-31355-8>. |
|
| 383 | + |
|
| 384 | +</div> |
|
| 385 | + |
|
| 373 | 386 | <div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry"> |
| 374 | 387 | |
| 375 | 388 | Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas |
| ... | ... | @@ -410,6 +423,16 @@ S. Hung, Elizabeth Chavez, Katsuyoshi Takata, et al. 2021. |
| 410 | 423 | |
| 411 | 424 | </div> |
| 412 | 425 | |
| 426 | +<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry"> |
|
| 427 | + |
|
| 428 | +Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, |
|
| 429 | +Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019. |
|
| 430 | +“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in |
|
| 431 | +Pediatric Endemic and Sporadic Burkitt Lymphoma.” *Blood* 133 (12): |
|
| 432 | +1313–24. <https://doi.org/10.1182/blood-2018-09-871418>. |
|
| 433 | + |
|
| 434 | +</div> |
|
| 435 | + |
|
| 413 | 436 | <div id="ref-hubschmannMutationalMechanismsShaping2021b" |
| 414 | 437 | class="csl-entry"> |
| 415 | 438 | |
| ... | ... | @@ -422,6 +445,14 @@ Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
| 422 | 445 | |
| 423 | 446 | </div> |
| 424 | 447 | |
| 448 | +<div id="ref-johnstonCmycHypermutationBurkitt1992" class="csl-entry"> |
|
| 449 | + |
|
| 450 | +Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in |
|
| 451 | +Burkitt’s Lymphoma.” *Leukemia & Lymphoma* 8 (6): 431–39. |
|
| 452 | +<https://doi.org/10.3109/10428199209051025>. |
|
| 453 | + |
|
| 454 | +</div> |
|
| 455 | + |
|
| 425 | 456 | <div id="ref-khodabakhshiRecurrentTargetsAberrant2012" |
| 426 | 457 | class="csl-entry"> |
| 427 | 458 | |
| ... | ... | @@ -497,6 +528,15 @@ Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8): |
| 497 | 528 | |
| 498 | 529 | </div> |
| 499 | 530 | |
| 531 | +<div id="ref-loveGeneticLandscapeMutations2012" class="csl-entry"> |
|
| 532 | + |
|
| 533 | +Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney |
|
| 534 | +Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of |
|
| 535 | +Mutations in Burkitt Lymphoma.” *Nature Genetics* 44 (12): 1321–25. |
|
| 536 | +<https://doi.org/10.1038/ng.2468>. |
|
| 537 | + |
|
| 538 | +</div> |
|
| 539 | + |
|
| 500 | 540 | <div id="ref-mareschalWholeExomeSequencing2016" class="csl-entry"> |
| 501 | 541 | |
| 502 | 542 | Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe |
| ... | ... | @@ -550,6 +590,15 @@ Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 (7): 1256–65. |
| 550 | 590 | |
| 551 | 591 | </div> |
| 552 | 592 | |
| 593 | +<div id="ref-muppidiLossSignalingGa132014b" class="csl-entry"> |
|
| 594 | + |
|
| 595 | +Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao, |
|
| 596 | +Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in |
|
| 597 | +Germinal Center B Cell-Derived Lymphoma.” *Nature* 516: 254–58. |
|
| 598 | +<https://doi.org/10.1038/nature13765>. |
|
| 599 | + |
|
| 600 | +</div> |
|
| 601 | + |
|
| 553 | 602 | <div id="ref-ngoOncogenicallyActiveMYD882011a" class="csl-entry"> |
| 554 | 603 | |
| 555 | 604 | Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, |
| ... | ... | @@ -581,6 +630,14 @@ in Follicular Lymphoma.” *Nature Genetics* 48 (2): 183–88. |
| 581 | 630 | |
| 582 | 631 | </div> |
| 583 | 632 | |
| 633 | +<div id="ref-paneaWholeGenomeLandscape2019" class="csl-entry"> |
|
| 634 | + |
|
| 635 | +Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A. |
|
| 636 | +Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt |
|
| 637 | +Lymphoma Subtypes.” *Blood*. <https://doi.org/10.1182/blood.2019001880>. |
|
| 638 | + |
|
| 639 | +</div> |
|
| 640 | + |
|
| 584 | 641 | <div id="ref-pararajalingamCodingNoncodingDrivers2020" |
| 585 | 642 | class="csl-entry"> |
| 586 | 643 | |
| ... | ... | @@ -643,6 +700,16 @@ and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171 |
| 643 | 700 | |
| 644 | 701 | </div> |
| 645 | 702 | |
| 703 | +<div id="ref-richterRecurrentMutationID32012a" class="csl-entry"> |
|
| 704 | + |
|
| 705 | +Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen |
|
| 706 | +Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent |
|
| 707 | +Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated |
|
| 708 | +Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 (12): |
|
| 709 | +1316–20. <https://doi.org/10.1038/ng.2469>. |
|
| 710 | + |
|
| 711 | +</div> |
|
| 712 | + |
|
| 646 | 713 | <div id="ref-rossiCodingGenomeSplenic2012c" class="csl-entry"> |
| 647 | 714 | |
| 648 | 715 | Rossi, Davide, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin, |
| ... | ... | @@ -724,6 +791,16 @@ Non-Hodgkin’s Lymphomas.” *Blood* 79 (1): 229–37. |
| 724 | 791 | |
| 725 | 792 | </div> |
| 726 | 793 | |
| 794 | +<div id="ref-thomasGeneticSubgroupsInform2023" class="csl-entry"> |
|
| 795 | + |
|
| 796 | +Thomas, Nicole, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, |
|
| 797 | +Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, et al. 2023. |
|
| 798 | +“Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt |
|
| 799 | +Lymphoma.” *Blood* 141 (8): 904–16. |
|
| 800 | +<https://doi.org/10.1182/blood.2022016534>. |
|
| 801 | + |
|
| 802 | +</div> |
|
| 803 | + |
|
| 727 | 804 | <div id="ref-tiacciBRAFMutationsHairycell2011a" class="csl-entry"> |
| 728 | 805 | |
| 729 | 806 | Tiacci, Enrico, Vladimir Trifonov, Gianluca Schiavoni, Antony Holmes, |
| ... | ... | @@ -742,6 +819,16 @@ Mutations in Marginal Zone Lymphoma.” *Haematologica* 93 (7): 1107–9. |
| 742 | 819 | |
| 743 | 820 | </div> |
| 744 | 821 | |
| 822 | +<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry"> |
|
| 823 | + |
|
| 824 | +Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and |
|
| 825 | +W. Woessmann. 2004. “Inactivation of the <span |
|
| 826 | +class="nocase">ARF-MDM-2-p53</span> Pathway in Sporadic Burkitt’s |
|
| 827 | +Lymphoma in Children.” *Leukemia* 18 (3): 584–88. |
|
| 828 | +<https://doi.org/10.1038/sj.leu.2403254>. |
|
| 829 | + |
|
| 830 | +</div> |
|
| 831 | + |
|
| 745 | 832 | <div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry"> |
| 746 | 833 | |
| 747 | 834 | Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter |
| ... | ... | @@ -760,4 +847,14 @@ class="nocase">B-cell</span> Lymphoma.” January. |
| 760 | 847 | |
| 761 | 848 | </div> |
| 762 | 849 | |
| 850 | +<div id="ref-zhouSporadicEndemicBurkitt2019" class="csl-entry"> |
|
| 851 | + |
|
| 852 | +Zhou, Peixun, Alex E. Blain, Alexander M. Newman, Masood Zaka, George |
|
| 853 | +Chagaluka, Filbert R. Adlar, Ugonna T. Offor, et al. 2019. “Sporadic and |
|
| 854 | +Endemic Burkitt Lymphoma Have Frequent FOXO1 Mutations but Distinct |
|
| 855 | +Hotspots in the AKT Recognition Motif.” *Blood Advances* 3 (14): |
|
| 856 | +2118–27. <https://doi.org/10.1182/bloodadvances.2018029546>. |
|
| 857 | + |
|
| 858 | +</div> |
|
| 859 | + |
|
| 763 | 860 | </div> |
FL_genes_with_bib.md
| ... | ... | @@ -1,130 +1,132 @@ |
| 1 | 1 | # FL genes |
| 2 | 2 | |
| 3 | +## Origins of FL genes |
|
| 4 | + |
|
| 3 | 5 | ## Tier 1 FL genes |
| 4 | 6 | |
| 5 | -| Gene | Tier | Relevant references | |
|
| 6 | -|:----------------------:|:----:|:------------------------------------------------:| |
|
| 7 | -| [ACTB](ACTB) | 1 | (Lohr et al. 2012) | |
|
| 8 | -| [ARID1A](ARID1A) | 1 | (Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 9 | -| [ATP6AP1](ATP6AP1) | 1 | (Okosun et al. 2016) | |
|
| 10 | -| [ATP6V1B2](ATP6V1B2) | 1 | (Okosun et al. 2016) | |
|
| 11 | -| [B2M](B2M) | 1 | (Morin et al. 2011) | |
|
| 12 | -| [BCL2](BCL2) | 1 | (Morin et al. 2011; Tanaka et al. 1992) | |
|
| 13 | -| [BCL6](BCL6) | 1 | (Morin et al. 2011) | |
|
| 14 | -| [BCL7A](BCL7A) | 1 | (Krysiak et al. 2017; Arthur et al. 2018) | |
|
| 15 | -| [BIRC6](BIRC6) | 1 | (Reddy et al. 2017) | |
|
| 16 | -| [BTG1](BTG1) | 1 | (Morin et al. 2011) | |
|
| 17 | -| [BTG2](BTG2) | 1 | (Morin et al. 2011) | |
|
| 18 | -| [BTK](BTK) | 1 | (Krysiak et al. 2017; Albuquerque et al. 2017) | |
|
| 19 | -| [CARD11](CARD11) | 1 | (Morin et al. 2011; Lenz et al. 2008) | |
|
| 20 | -| [CCND3](CCND3) | 1 | (Morin et al. 2011) | |
|
| 21 | -| [CD83](CD83) | 1 | (Russler-Germain et al. 2023; Morin et al. 2013) | |
|
| 22 | -| [CREBBP](CREBBP) | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | |
|
| 23 | -| [CTSS](CTSS) | 1 | (Bararia et al. 2020) | |
|
| 24 | -| [DTX1](DTX1) | 1 | (Schmitz et al. 2018) | |
|
| 25 | -| [EBF1](EBF1) | 1 | (Bohle et al. 2013) | |
|
| 26 | -| [EEF1A1](EEF1A1) | 1 | (Hübschmann et al. 2021) | |
|
| 27 | -| [EP300](EP300) | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011) | |
|
| 28 | -| [EZH2](EZH2) | 1 | (Morin et al. 2010) | |
|
| 29 | -| [FAS](FAS) | 1 | (Scholl et al. 2007) | |
|
| 30 | -| [FOXO1](FOXO1) | 1 | (Morin et al. 2011) | |
|
| 31 | -| [GNA13](GNA13) | 1 | (Morin et al. 2011) | |
|
| 32 | -| [GNAI2](GNAI2) | 1 | (Morin et al. 2013) | |
|
| 33 | -| [HIST1H1B](HIST1H1B) | 1 | (Krysiak et al. 2017; Chapuy et al. 2018) | |
|
| 34 | -| [HIST1H1C](HIST1H1C) | 1 | (Morin et al. 2011) | |
|
| 35 | -| [HIST1H1D](HIST1H1D) | 1 | (Krysiak et al. 2017; Morin et al. 2013) | |
|
| 36 | -| [HIST1H1E](HIST1H1E) | 1 | (Krysiak et al. 2017; Morin et al. 2013) | |
|
| 37 | -| [HIST1H2AC](HIST1H2AC) | 1 | (Krysiak et al. 2017; Morin et al. 2013) | |
|
| 38 | -| [HIST1H2AG](HIST1H2AG) | 1 | (Krysiak et al. 2017; Morin et al. 2013) | |
|
| 39 | -| [HIST1H2AM](HIST1H2AM) | 1 | (Krysiak et al. 2017) | |
|
| 40 | -| [HIST1H2BC](HIST1H2BC) | 1 | (Krysiak et al. 2017; Reddy et al. 2017) | |
|
| 41 | -| [HIST1H2BD](HIST1H2BD) | 1 | (Krysiak et al. 2017) | |
|
| 42 | -| [HIST1H2BG](HIST1H2BG) | 1 | (Krysiak et al. 2017) | |
|
| 43 | -| [HIST1H3B](HIST1H3B) | 1 | (Zhang et al. 2013) | |
|
| 44 | -| [HIST1H3G](HIST1H3G) | 1 | (Krysiak et al. 2017) | |
|
| 45 | -| [HVCN1](HVCN1) | 1 | (Krysiak et al. 2017) | |
|
| 46 | -| [IRF4](IRF4) | 1 | (Morin et al. 2011) | |
|
| 47 | -| [IRF8](IRF8) | 1 | (Morin et al. 2011) | |
|
| 48 | -| [ITPKB](ITPKB) | 1 | (Schmitz et al. 2018) | |
|
| 49 | -| [KLF2](KLF2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 50 | -| [KLHL6](KLHL6) | 1 | (Morin et al. 2011) | |
|
| 51 | -| [KMT2D](KMT2D) | 1 | (Morin et al. 2011) | |
|
| 52 | -| [LTB](LTB) | 1 | (Chapuy et al. 2018) | |
|
| 53 | -| [MAP2K1](MAP2K1) | 1 | (Louissaint et al. 2016; Shin et al. 2015) | |
|
| 54 | -| [MEF2B](MEF2B) | 1 | (Morin et al. 2011) | |
|
| 55 | -| [MEF2C](MEF2C) | 1 | (Arthur et al. 2018) | |
|
| 56 | -| [PCLO](PCLO) | 1 | (Lohr et al. 2012) | |
|
| 57 | -| [PIM1](PIM1) | 1 | (L. Pasqualucci et al. 2001) | |
|
| 58 | -| [POU2AF1](POU2AF1) | 1 | (Krysiak et al. 2017) | |
|
| 59 | -| [POU2F2](POU2F2) | 1 | (Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 60 | -| [PTPRD](PTPRD) | 1 | | |
|
| 61 | -| [RRAGC](RRAGC) | 1 | (Okosun et al. 2016) | |
|
| 62 | -| [S1PR2](S1PR2) | 1 | (Morin et al. 2011) | |
|
| 63 | -| [SGK1](SGK1) | 1 | (Morin et al. 2011) | |
|
| 64 | -| [SMARCA4](SMARCA4) | 1 | (Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 65 | -| [SOCS1](SOCS1) | 1 | (Morin et al. 2011) | |
|
| 66 | -| [STAT6](STAT6) | 1 | (Yildiz et al. 2015) | |
|
| 67 | -| [TBL1XR1](TBL1XR1) | 1 | (Mareschal et al. 2016) | |
|
| 68 | -| [TMSB4X](TMSB4X) | 1 | (Albuquerque et al. 2017) | |
|
| 69 | -| [TNFAIP3](TNFAIP3) | 1 | (Compagno et al. 2009) | |
|
| 70 | -| [TNFRSF14](TNFRSF14) | 1 | (Cheung et al. 2010) | |
|
| 71 | -| [TP53](TP53) | 1 | (Morin et al. 2011) | |
|
| 72 | -| [VMA21](VMA21) | 1 | (Hübschmann et al. 2021) | |
|
| 7 | +| Gene | Tier | Relevant references | |
|
| 8 | +|:----------------------:|:----:|:-------------------------------------------------------------------:| |
|
| 9 | +| [ACTB](ACTB) | 1 | (Lohr et al. 2012) | |
|
| 10 | +| [ARID1A](ARID1A) | 1 | (Krysiak et al. 2017; Zhang et al. 2013; Love et al. 2012) | |
|
| 11 | +| [ATP6AP1](ATP6AP1) | 1 | (Okosun et al. 2016) | |
|
| 12 | +| [ATP6V1B2](ATP6V1B2) | 1 | (Okosun et al. 2016) | |
|
| 13 | +| [B2M](B2M) | 1 | (Morin et al. 2011) | |
|
| 14 | +| [BCL2](BCL2) | 1 | (Morin et al. 2011; Tanaka et al. 1992; Burkhardt et al. 2022) | |
|
| 15 | +| [BCL6](BCL6) | 1 | (Morin et al. 2011; Love et al. 2012) | |
|
| 16 | +| [BCL7A](BCL7A) | 1 | (Krysiak et al. 2017; Arthur et al. 2018; Grande et al. 2019) | |
|
| 17 | +| [BIRC6](BIRC6) | 1 | (Reddy et al. 2017) | |
|
| 18 | +| [BTG1](BTG1) | 1 | (Morin et al. 2011; Burkhardt et al. 2022) | |
|
| 19 | +| [BTG2](BTG2) | 1 | (Morin et al. 2011; Love et al. 2012) | |
|
| 20 | +| [BTK](BTK) | 1 | (Krysiak et al. 2017; Albuquerque et al. 2017) | |
|
| 21 | +| [CARD11](CARD11) | 1 | (Morin et al. 2011; Lenz et al. 2008; Panea et al. 2019) | |
|
| 22 | +| [CCND3](CCND3) | 1 | (Morin et al. 2011; Richter et al. 2012) | |
|
| 23 | +| [CD83](CD83) | 1 | (Russler-Germain et al. 2023; Morin et al. 2013; Panea et al. 2019) | |
|
| 24 | +| [CREBBP](CREBBP) | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011; Love et al. 2012) | |
|
| 25 | +| [CTSS](CTSS) | 1 | (Bararia et al. 2020) | |
|
| 26 | +| [DTX1](DTX1) | 1 | (Schmitz et al. 2018; Panea et al. 2019) | |
|
| 27 | +| [EBF1](EBF1) | 1 | \[Bohle et al. (2013); @\] | |
|
| 28 | +| [EEF1A1](EEF1A1) | 1 | (Hübschmann et al. 2021) | |
|
| 29 | +| [EP300](EP300) | 1 | \[Laura Pasqualucci, Dominguez-Sola, et al. (2011); @\] | |
|
| 30 | +| [EZH2](EZH2) | 1 | (Morin et al. 2010; Love et al. 2012) | |
|
| 31 | +| [FAS](FAS) | 1 | (Scholl et al. 2007) | |
|
| 32 | +| [FOXO1](FOXO1) | 1 | (Morin et al. 2011; Schmitz et al. 2012) | |
|
| 33 | +| [GNA13](GNA13) | 1 | (Morin et al. 2011; Love et al. 2012) | |
|
| 34 | +| [GNAI2](GNAI2) | 1 | (Morin et al. 2013; Grande et al. 2019) | |
|
| 35 | +| [HIST1H1B](HIST1H1B) | 1 | (Krysiak et al. 2017; Chapuy et al. 2018) | |
|
| 36 | +| [HIST1H1C](HIST1H1C) | 1 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 37 | +| [HIST1H1D](HIST1H1D) | 1 | (Krysiak et al. 2017; Morin et al. 2013) | |
|
| 38 | +| [HIST1H1E](HIST1H1E) | 1 | (Krysiak et al. 2017; Morin et al. 2013; Grande et al. 2019) | |
|
| 39 | +| [HIST1H2AC](HIST1H2AC) | 1 | (Krysiak et al. 2017; Morin et al. 2013) | |
|
| 40 | +| [HIST1H2AG](HIST1H2AG) | 1 | (Krysiak et al. 2017; Morin et al. 2013; Panea et al. 2019) | |
|
| 41 | +| [HIST1H2AM](HIST1H2AM) | 1 | (Krysiak et al. 2017; Panea et al. 2019) | |
|
| 42 | +| [HIST1H2BC](HIST1H2BC) | 1 | (Krysiak et al. 2017; Reddy et al. 2017) | |
|
| 43 | +| [HIST1H2BD](HIST1H2BD) | 1 | (Krysiak et al. 2017) | |
|
| 44 | +| [HIST1H2BG](HIST1H2BG) | 1 | (Krysiak et al. 2017) | |
|
| 45 | +| [HIST1H3B](HIST1H3B) | 1 | (Zhang et al. 2013) | |
|
| 46 | +| [HIST1H3G](HIST1H3G) | 1 | (Krysiak et al. 2017) | |
|
| 47 | +| [HVCN1](HVCN1) | 1 | (Krysiak et al. 2017) | |
|
| 48 | +| [IRF4](IRF4) | 1 | (Morin et al. 2011) | |
|
| 49 | +| [IRF8](IRF8) | 1 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 50 | +| [ITPKB](ITPKB) | 1 | (Schmitz et al. 2018) | |
|
| 51 | +| [KLF2](KLF2) | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) | |
|
| 52 | +| [KLHL6](KLHL6) | 1 | \[Morin et al. (2011); @\] | |
|
| 53 | +| [KMT2D](KMT2D) | 1 | (Morin et al. 2011; Grande et al. 2019) | |
|
| 54 | +| [LTB](LTB) | 1 | \[Chapuy et al. (2018); @\] | |
|
| 55 | +| [MAP2K1](MAP2K1) | 1 | (Louissaint et al. 2016; Shin et al. 2015) | |
|
| 56 | +| [MEF2B](MEF2B) | 1 | \[Morin et al. (2011); @\] | |
|
| 57 | +| [MEF2C](MEF2C) | 1 | (Arthur et al. 2018) | |
|
| 58 | +| [PCLO](PCLO) | 1 | (Lohr et al. 2012) | |
|
| 59 | +| [PIM1](PIM1) | 1 | (L. Pasqualucci et al. 2001; Burkhardt et al. 2022) | |
|
| 60 | +| [POU2AF1](POU2AF1) | 1 | (Krysiak et al. 2017) | |
|
| 61 | +| [POU2F2](POU2F2) | 1 | (Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 62 | +| [PTPRD](PTPRD) | 1 | | |
|
| 63 | +| [RRAGC](RRAGC) | 1 | (Okosun et al. 2016) | |
|
| 64 | +| [S1PR2](S1PR2) | 1 | (Morin et al. 2011; Muppidi et al. 2014) | |
|
| 65 | +| [SGK1](SGK1) | 1 | (Morin et al. 2011) | |
|
| 66 | +| [SMARCA4](SMARCA4) | 1 | (Krysiak et al. 2017; Zhang et al. 2013; Richter et al. 2012) | |
|
| 67 | +| [SOCS1](SOCS1) | 1 | (Morin et al. 2011) | |
|
| 68 | +| [STAT6](STAT6) | 1 | (Yildiz et al. 2015) | |
|
| 69 | +| [TBL1XR1](TBL1XR1) | 1 | (Mareschal et al. 2016) | |
|
| 70 | +| [TMSB4X](TMSB4X) | 1 | (Albuquerque et al. 2017) | |
|
| 71 | +| [TNFAIP3](TNFAIP3) | 1 | (Compagno et al. 2009) | |
|
| 72 | +| [TNFRSF14](TNFRSF14) | 1 | (Cheung et al. 2010) | |
|
| 73 | +| [TP53](TP53) | 1 | (Morin et al. 2011; Wilda et al. 2004) | |
|
| 74 | +| [VMA21](VMA21) | 1 | (Hübschmann et al. 2021) | |
|
| 73 | 75 | |
| 74 | 76 | ## Tier 2 FL genes |
| 75 | 77 | |
| 76 | -| Gene | Tier | Relevant references | |
|
| 77 | -|:----------------------:|:----:|:------------------------------------------------:| |
|
| 78 | -| [ABL2](ABL2) | 2 | (Russler-Germain et al. 2023) | |
|
| 79 | -| [ACTG1](ACTG1) | 2 | (Hübschmann et al. 2021) | |
|
| 80 | -| [ATP6V1A](ATP6V1A) | 2 | (Hübschmann et al. 2021) | |
|
| 81 | -| [BCL10](BCL10) | 2 | (Russler-Germain et al. 2023; Morin et al. 2011) | |
|
| 82 | -| [CCDC42BPB](CCDC42BPB) | 2 | (Hübschmann et al. 2021) | |
|
| 83 | -| [CD70](CD70) | 2 | (Russler-Germain et al. 2023; Morin et al. 2011) | |
|
| 84 | -| [CD79B](CD79B) | 2 | (Morin et al. 2011) | |
|
| 85 | -| [CILP](CILP) | 2 | (Russler-Germain et al. 2023) | |
|
| 86 | -| [CPNE8](CPNE8) | 2 | (Hübschmann et al. 2021) | |
|
| 87 | -| [CXCR4](CXCR4) | 2 | (Krysiak et al. 2017; Khodabakhshi et al. 2012) | |
|
| 88 | -| [CYP2A6](CYP2A6) | 2 | (Russler-Germain et al. 2023) | |
|
| 89 | -| [DDX3X](DDX3X) | 2 | (Schmitz et al. 2018) | |
|
| 90 | -| [DHX15](DHX15) | 2 | (Hübschmann et al. 2021) | |
|
| 91 | -| [DUSP2](DUSP2) | 2 | (Morin et al. 2013) | |
|
| 92 | -| [EGR1](EGR1) | 2 | (Krysiak et al. 2017) | |
|
| 93 | -| [FZR1](FZR1) | 2 | (Hübschmann et al. 2021) | |
|
| 94 | -| [GBP7](GBP7) | 2 | (Russler-Germain et al. 2023) | |
|
| 95 | -| [GRM6](GRM6) | 2 | (Russler-Germain et al. 2023) | |
|
| 96 | -| [HIST1H2BM](HIST1H2BM) | 2 | (Krysiak et al. 2017) | |
|
| 97 | -| [HIST1H3I](HIST1H3I) | 2 | (Krysiak et al. 2017) | |
|
| 98 | -| [HLA-B](HLA-B) | 2 | | |
|
| 99 | -| [HNRNPD](HNRNPD) | 2 | | |
|
| 100 | -| [IGLL5](IGLL5) | 2 | (Russler-Germain et al. 2023) | |
|
| 101 | -| [JUP](JUP) | 2 | (Hübschmann et al. 2021) | |
|
| 102 | -| [KIR3DL1](KIR3DL1) | 2 | (Russler-Germain et al. 2023) | |
|
| 103 | -| [LAPTM5](LAPTM5) | 2 | (Hübschmann et al. 2021) | |
|
| 104 | -| [MAGEC1](MAGEC1) | 2 | (Russler-Germain et al. 2023) | |
|
| 105 | -| [MAP7D1](MAP7D1) | 2 | (Russler-Germain et al. 2023) | |
|
| 106 | -| [MGEA5](MGEA5) | 2 | (Hübschmann et al. 2021) | |
|
| 107 | -| [MKI67](MKI67) | 2 | (Russler-Germain et al. 2023) | |
|
| 108 | -| [MYC](MYC) | 2 | (L. Pasqualucci et al. 2001) | |
|
| 109 | -| [MYCBP2](MYCBP2) | 2 | (Hübschmann et al. 2021) | |
|
| 110 | -| [MYD88](MYD88) | 2 | (Ngo et al. 2011) | |
|
| 111 | -| [NFKBIA](NFKBIA) | 2 | (Russler-Germain et al. 2023; Lake et al. 2009) | |
|
| 112 | -| [OR8H2](OR8H2) | 2 | (Russler-Germain et al. 2023) | |
|
| 113 | -| [P2RY8](P2RY8) | 2 | (Lohr et al. 2012) | |
|
| 114 | -| [PDS5B](PDS5B) | 2 | (Hübschmann et al. 2021; Morin et al. 2013) | |
|
| 115 | -| [PPP4C](PPP4C) | 2 | (Hübschmann et al. 2021) | |
|
| 116 | -| [PRKDC](PRKDC) | 2 | (Hübschmann et al. 2021; Schmitz et al. 2018) | |
|
| 117 | -| [PZP](PZP) | 2 | (Russler-Germain et al. 2023) | |
|
| 118 | -| [RBM6](RBM6) | 2 | (Hübschmann et al. 2021) | |
|
| 119 | -| [SESN1](SESN1) | 2 | (Oricchio et al. 2017) | |
|
| 120 | -| [SHROOM3](SHROOM3) | 2 | (Russler-Germain et al. 2023) | |
|
| 121 | -| [SRRM2](SRRM2) | 2 | (Russler-Germain et al. 2023; Morin et al. 2013) | |
|
| 122 | -| [STAB2](STAB2) | 2 | (Russler-Germain et al. 2023) | |
|
| 123 | -| [TMEM30A](TMEM30A) | 2 | (Morin et al. 2011) | |
|
| 124 | -| [TPP1](TPP1) | 2 | (Hübschmann et al. 2021) | |
|
| 125 | -| [XIRP2](XIRP2) | 2 | (Russler-Germain et al. 2023) | |
|
| 126 | -| [ZC3H12A](ZC3H12A) | 2 | (Arthur et al. 2018) | |
|
| 127 | -| [ZNF608](ZNF608) | 2 | (Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 78 | +| Gene | Tier | Relevant references | |
|
| 79 | +|:----------------------:|:----:|:------------------------------------------------------------------:| |
|
| 80 | +| [ABL2](ABL2) | 2 | (Russler-Germain et al. 2023) | |
|
| 81 | +| [ACTG1](ACTG1) | 2 | (Hübschmann et al. 2021) | |
|
| 82 | +| [ATP6V1A](ATP6V1A) | 2 | (Hübschmann et al. 2021) | |
|
| 83 | +| [BCL10](BCL10) | 2 | (Russler-Germain et al. 2023; Morin et al. 2011) | |
|
| 84 | +| [CCDC42BPB](CCDC42BPB) | 2 | (Hübschmann et al. 2021) | |
|
| 85 | +| [CD70](CD70) | 2 | (Russler-Germain et al. 2023; Morin et al. 2011) | |
|
| 86 | +| [CD79B](CD79B) | 2 | (Morin et al. 2011; Panea et al. 2019) | |
|
| 87 | +| [CILP](CILP) | 2 | (Russler-Germain et al. 2023) | |
|
| 88 | +| [CPNE8](CPNE8) | 2 | (Hübschmann et al. 2021) | |
|
| 89 | +| [CXCR4](CXCR4) | 2 | (Krysiak et al. 2017; Khodabakhshi et al. 2012; Panea et al. 2019) | |
|
| 90 | +| [CYP2A6](CYP2A6) | 2 | (Russler-Germain et al. 2023) | |
|
| 91 | +| [DDX3X](DDX3X) | 2 | (Schmitz et al. 2018, 2012) | |
|
| 92 | +| [DHX15](DHX15) | 2 | (Hübschmann et al. 2021) | |
|
| 93 | +| [DUSP2](DUSP2) | 2 | (Morin et al. 2013) | |
|
| 94 | +| [EGR1](EGR1) | 2 | (Krysiak et al. 2017) | |
|
| 95 | +| [FZR1](FZR1) | 2 | (Hübschmann et al. 2021) | |
|
| 96 | +| [GBP7](GBP7) | 2 | (Russler-Germain et al. 2023) | |
|
| 97 | +| [GRM6](GRM6) | 2 | (Russler-Germain et al. 2023) | |
|
| 98 | +| [HIST1H2BM](HIST1H2BM) | 2 | (Krysiak et al. 2017) | |
|
| 99 | +| [HIST1H3I](HIST1H3I) | 2 | (Krysiak et al. 2017; Panea et al. 2019) | |
|
| 100 | +| [HLA-B](HLA-B) | 2 | \[@\] | |
|
| 101 | +| [HNRNPD](HNRNPD) | 2 | | |
|
| 102 | +| [IGLL5](IGLL5) | 2 | (Russler-Germain et al. 2023; Panea et al. 2019) | |
|
| 103 | +| [JUP](JUP) | 2 | (Hübschmann et al. 2021) | |
|
| 104 | +| [KIR3DL1](KIR3DL1) | 2 | (Russler-Germain et al. 2023) | |
|
| 105 | +| [LAPTM5](LAPTM5) | 2 | (Hübschmann et al. 2021) | |
|
| 106 | +| [MAGEC1](MAGEC1) | 2 | (Russler-Germain et al. 2023) | |
|
| 107 | +| [MAP7D1](MAP7D1) | 2 | (Russler-Germain et al. 2023) | |
|
| 108 | +| [MGEA5](MGEA5) | 2 | (Hübschmann et al. 2021) | |
|
| 109 | +| [MKI67](MKI67) | 2 | (Russler-Germain et al. 2023; Schmitz et al. 2012) | |
|
| 110 | +| [MYC](MYC) | 2 | (L. Pasqualucci et al. 2001; Johnston and Carroll 1992) | |
|
| 111 | +| [MYCBP2](MYCBP2) | 2 | (Hübschmann et al. 2021) | |
|
| 112 | +| [MYD88](MYD88) | 2 | (Ngo et al. 2011) | |
|
| 113 | +| [NFKBIA](NFKBIA) | 2 | (Russler-Germain et al. 2023; Lake et al. 2009) | |
|
| 114 | +| [OR8H2](OR8H2) | 2 | (Russler-Germain et al. 2023) | |
|
| 115 | +| [P2RY8](P2RY8) | 2 | (Lohr et al. 2012; Muppidi et al. 2014) | |
|
| 116 | +| [PDS5B](PDS5B) | 2 | (Hübschmann et al. 2021; Morin et al. 2013) | |
|
| 117 | +| [PPP4C](PPP4C) | 2 | (Hübschmann et al. 2021) | |
|
| 118 | +| [PRKDC](PRKDC) | 2 | (Hübschmann et al. 2021; Schmitz et al. 2018) | |
|
| 119 | +| [PZP](PZP) | 2 | (Russler-Germain et al. 2023) | |
|
| 120 | +| [RBM6](RBM6) | 2 | (Hübschmann et al. 2021) | |
|
| 121 | +| [SESN1](SESN1) | 2 | (Oricchio et al. 2017) | |
|
| 122 | +| [SHROOM3](SHROOM3) | 2 | (Russler-Germain et al. 2023) | |
|
| 123 | +| [SRRM2](SRRM2) | 2 | (Russler-Germain et al. 2023; Morin et al. 2013) | |
|
| 124 | +| [STAB2](STAB2) | 2 | (Russler-Germain et al. 2023) | |
|
| 125 | +| [TMEM30A](TMEM30A) | 2 | (Morin et al. 2011) | |
|
| 126 | +| [TPP1](TPP1) | 2 | (Hübschmann et al. 2021) | |
|
| 127 | +| [XIRP2](XIRP2) | 2 | (Russler-Germain et al. 2023) | |
|
| 128 | +| [ZC3H12A](ZC3H12A) | 2 | (Arthur et al. 2018) | |
|
| 129 | +| [ZNF608](ZNF608) | 2 | (Krysiak et al. 2017; Zhang et al. 2013) | |
|
| 128 | 130 | |
| 129 | 131 | # References |
| 130 | 132 | |
| ... | ... | @@ -170,6 +172,17 @@ Lymphoma.” *Leukemia* 27 (3): 671–79. |
| 170 | 172 | |
| 171 | 173 | </div> |
| 172 | 174 | |
| 175 | +<div id="ref-burkhardtClinicalRelevanceMolecular2022b" |
|
| 176 | +class="csl-entry"> |
|
| 177 | + |
|
| 178 | +Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp |
|
| 179 | +Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance |
|
| 180 | +of Molecular Characteristics in Burkitt Lymphoma Differs According to |
|
| 181 | +Age.” *Nature Communications* 13 (1): 3881. |
|
| 182 | +<https://doi.org/10.1038/s41467-022-31355-8>. |
|
| 183 | + |
|
| 184 | +</div> |
|
| 185 | + |
|
| 173 | 186 | <div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry"> |
| 174 | 187 | |
| 175 | 188 | Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas |
| ... | ... | @@ -201,6 +214,16 @@ class="nocase">B-cell</span> Lymphoma.” *Nature* 459 (7247): 717–21. |
| 201 | 214 | |
| 202 | 215 | </div> |
| 203 | 216 | |
| 217 | +<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry"> |
|
| 218 | + |
|
| 219 | +Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, |
|
| 220 | +Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019. |
|
| 221 | +“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in |
|
| 222 | +Pediatric Endemic and Sporadic Burkitt Lymphoma.” *Blood* 133 (12): |
|
| 223 | +1313–24. <https://doi.org/10.1182/blood-2018-09-871418>. |
|
| 224 | + |
|
| 225 | +</div> |
|
| 226 | + |
|
| 204 | 227 | <div id="ref-hubschmannMutationalMechanismsShaping2021b" |
| 205 | 228 | class="csl-entry"> |
| 206 | 229 | |
| ... | ... | @@ -213,6 +236,14 @@ Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
| 213 | 236 | |
| 214 | 237 | </div> |
| 215 | 238 | |
| 239 | +<div id="ref-johnstonCmycHypermutationBurkitt1992" class="csl-entry"> |
|
| 240 | + |
|
| 241 | +Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in |
|
| 242 | +Burkitt’s Lymphoma.” *Leukemia & Lymphoma* 8 (6): 431–39. |
|
| 243 | +<https://doi.org/10.3109/10428199209051025>. |
|
| 244 | + |
|
| 245 | +</div> |
|
| 246 | + |
|
| 216 | 247 | <div id="ref-khodabakhshiRecurrentTargetsAberrant2012" |
| 217 | 248 | class="csl-entry"> |
| 218 | 249 | |
| ... | ... | @@ -278,6 +309,15 @@ Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 (8): |
| 278 | 309 | |
| 279 | 310 | </div> |
| 280 | 311 | |
| 312 | +<div id="ref-loveGeneticLandscapeMutations2012" class="csl-entry"> |
|
| 313 | + |
|
| 314 | +Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney |
|
| 315 | +Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of |
|
| 316 | +Mutations in Burkitt Lymphoma.” *Nature Genetics* 44 (12): 1321–25. |
|
| 317 | +<https://doi.org/10.1038/ng.2468>. |
|
| 318 | + |
|
| 319 | +</div> |
|
| 320 | + |
|
| 281 | 321 | <div id="ref-mareschalWholeExomeSequencing2016" class="csl-entry"> |
| 282 | 322 | |
| 283 | 323 | Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe |
| ... | ... | @@ -320,6 +360,15 @@ Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 (7): 1256–65. |
| 320 | 360 | |
| 321 | 361 | </div> |
| 322 | 362 | |
| 363 | +<div id="ref-muppidiLossSignalingGa132014b" class="csl-entry"> |
|
| 364 | + |
|
| 365 | +Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao, |
|
| 366 | +Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in |
|
| 367 | +Germinal Center B Cell-Derived Lymphoma.” *Nature* 516: 254–58. |
|
| 368 | +<https://doi.org/10.1038/nature13765>. |
|
| 369 | + |
|
| 370 | +</div> |
|
| 371 | + |
|
| 323 | 372 | <div id="ref-ngoOncogenicallyActiveMYD882011a" class="csl-entry"> |
| 324 | 373 | |
| 325 | 374 | Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, |
| ... | ... | @@ -352,6 +401,14 @@ eaak9969. <https://doi.org/10.1126/scitranslmed.aak9969>. |
| 352 | 401 | |
| 353 | 402 | </div> |
| 354 | 403 | |
| 404 | +<div id="ref-paneaWholeGenomeLandscape2019" class="csl-entry"> |
|
| 405 | + |
|
| 406 | +Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A. |
|
| 407 | +Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt |
|
| 408 | +Lymphoma Subtypes.” *Blood*. <https://doi.org/10.1182/blood.2019001880>. |
|
| 409 | + |
|
| 410 | +</div> |
|
| 411 | + |
|
| 355 | 412 | <div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a" |
| 356 | 413 | class="csl-entry"> |
| 357 | 414 | |
| ... | ... | @@ -393,6 +450,16 @@ and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171 |
| 393 | 450 | |
| 394 | 451 | </div> |
| 395 | 452 | |
| 453 | +<div id="ref-richterRecurrentMutationID32012a" class="csl-entry"> |
|
| 454 | + |
|
| 455 | +Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen |
|
| 456 | +Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent |
|
| 457 | +Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated |
|
| 458 | +Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 (12): |
|
| 459 | +1316–20. <https://doi.org/10.1038/ng.2469>. |
|
| 460 | + |
|
| 461 | +</div> |
|
| 462 | + |
|
| 396 | 463 | <div id="ref-russler-germainMutationsAssociatedProgression2023b" |
| 397 | 464 | class="csl-entry"> |
| 398 | 465 | |
| ... | ... | @@ -415,6 +482,16 @@ England Journal of Medicine* 378 (15): 1396–1407. |
| 415 | 482 | |
| 416 | 483 | </div> |
| 417 | 484 | |
| 485 | +<div id="ref-schmitzBurkittLymphomaPathogenesis2012" class="csl-entry"> |
|
| 486 | + |
|
| 487 | +Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, |
|
| 488 | +Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma |
|
| 489 | +Pathogenesis and Therapeutic Targets from Structural and Functional |
|
| 490 | +Genomics.” *Nature* 490 (7418): 116–20. |
|
| 491 | +<https://doi.org/10.1038/nature11378>. |
|
| 492 | + |
|
| 493 | +</div> |
|
| 494 | + |
|
| 418 | 495 | <div id="ref-schollMutationsRegionFAS2007" class="csl-entry"> |
| 419 | 496 | |
| 420 | 497 | Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector, |
| ... | ... | @@ -443,6 +520,16 @@ Non-Hodgkin’s Lymphomas.” *Blood* 79 (1): 229–37. |
| 443 | 520 | |
| 444 | 521 | </div> |
| 445 | 522 | |
| 523 | +<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry"> |
|
| 524 | + |
|
| 525 | +Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and |
|
| 526 | +W. Woessmann. 2004. “Inactivation of the <span |
|
| 527 | +class="nocase">ARF-MDM-2-p53</span> Pathway in Sporadic Burkitt’s |
|
| 528 | +Lymphoma in Children.” *Leukemia* 18 (3): 584–88. |
|
| 529 | +<https://doi.org/10.1038/sj.leu.2403254>. |
|
| 530 | + |
|
| 531 | +</div> |
|
| 532 | + |
|
| 446 | 533 | <div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry"> |
| 447 | 534 | |
| 448 | 535 | Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter |